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Here we developed multiple genetic systems through which genetic modifications driven 
by DNA breaks caused by the I-SceI nuclease can be assayed in the yeast Saccharomyces 
cerevisiae and in human cells. Using the delitto perfetto approach for site-directed 
mutagenesis in yeast, we generated isogenic strains in which we could directly compare 
the recombination potential of different I-SceI variants. By genetic engineering 
procedures, we generated constructs in human cells for testing the recombination activity 
of the same I-SceI variants. Both in yeast and human cells we performed genetic 
correction experiments using oligonucleotides (oligos) following modification and/or 
optimization of existing gene targeting protocols and development of new ones. We 
demonstrated that an I-SceI nicking enzyme can stimulate recombination on the 
chromosome in S. cerevisiae at multiple genomic loci. We also demonstrated in yeast that 
an I-SceI-driven nick can activate recombination 10 kb distant from the initial site of the 
chromosomal lesion. Moreover we demonstrated that an I-SceI nick can stimulate 
recombination at the site of the nick at episomal and chromosomal loci in human cells. 
We showed that an I-SceI double-strand break (DSB) could trigger recombination up to 2 
kb distant from the site of the break at an episomal target locus in human cells, though the 
same was not observed for the nick. Overall, we demonstrated the capacity for I-SceI 
nick-induced recombination in yeast and human cells. Importantly, our findings reveal 
that the nick stimulates gene correction by oligos differently from a DSB lesion, as 
determined by genetic and molecular analyses in yeast and human cells. This research 








1.1 GENETIC MODIFICATION AND GENETIC DISORDERS 
Many diseases are considered monogenic and are caused, at least primarily, by mutations 
in a single gene. These include sickle cell anemia, muscular dystrophy, hemophilia types 
A and B, forms of severe combined immunodeficiency (SCID), Rett syndrome, retinitis 
pigmentosa, cystic fibrosis, and phenylketonuria [1-12]. Because of the harm an afflicted 
individual endures if the disease is left untreated, scientists have focused on different 
ways in which the normal protein lost due to the genetic mutation could be provided. 
Thus, two strategies for gene therapy have emerged: treatment of the disease through 
integration of the functional gene somewhere in the genome and treatment through gene 
targeting to fix the mutant allele at the endogenous locus.  
 
1.1.1 Gene therapy through integration of the functional gene in the genome 
For many devastating disorders, a dysfunction occurs due to a mutation in a single gene 
causing a misfolded, truncated, or otherwise mutant protein [13]. While some diseases, 
like phenylketonuria, can be at least partially remedied by a simple dietary change, some 
others are much more complex [11]. In order to supplement the loss of the endogenously-
encoded protein, gene therapy can be used to deliver a functional copy of the gene. 




viral vectors [14,15]. Using this type of gene therapy, successful treatments of adenosine-
deaminase (ADA) SCID and x-linked SCID (SCID-X) as well as hemophilia A and 
hemophilia B have been reported in various studies [2,3,16-19]. A major drawback to this 
type of approach, however, is the risk of insertional mutagenesis. In a highly-publicized 
case study, three patients successfully treated for SCID-X later developed leukemia after 
the lentiviral vector used for therapy integrated within an oncogene [4]. As a 
consequence, scientists have focused their efforts on integration into so-called “safe 
harbor” loci – those in which targeted insertion of a gene has been shown to minimally 
affect the endogenous locus while allowing for adequate expression of the new genetic 
material [20-22]. However, the natural genetic locus retains the original, mutated 
sequence. 
 
1.1.2 Gene therapy through targeted gene correction at the endogenous locus 
Another type of gene therapy is gene targeting, which is a technique that can be used to 
directly integrate the normal or modified deoxyribonucleic acid (DNA) sequence of a 
gene of interest into its natural endogenous chromosomal position. It has been widely 
used in many organisms and cell types including the yeast Saccharomyces cerevisiae, the 
slime mold Dictyostelium discoideum, the moss Physcomitrella patens, mouse embryonic 
stem cells, and human cells [23-35]. The principle of this technique is that an endogenous 
chromosomal locus can be directly targeted for replacement with a similar sequence from 
an exogenous template rather than the random integration approach often used in 
traditional gene therapy [31]. This exchange relies on the cellular homologous 




a variety of genetic manipulations can be made including deletions, insertions, and other 
point mutations [31,36]. Applications include functional analysis of a protein through 
deletion of its genetic coding sequence, providing an added selective advantage through 
insertion of a selectable marker such as one encoding a fluorescent protein or one 
providing antibiotic resistance, and replacement of mutant alleles with corrected 
sequences in order to restore proper protein function [36]. In particular, the latter of these 
applications provides great implications for genetic disorders as it presents a treatment 
option to “cure” a disease at the genomic level by removing the mutant form of the 
culprit gene and replacing it with the functional copy. 
 
1.2 THE ROLE OF A DNA DOUBLE-STRAND BREAK (DSB) IN HR 
HR is a natural process involved in meiotic recombination and in repair of DNA mitotic  
DSBs [37]. It has been studied in many organisms, with much research conducted in the 
yeast model [38-40]. In meiotic recombination it allows for exchange between 
homologous chromosomes in the first meiotic division which can generate genetic 
variation [41]. In mitotic recombination it naturally repairs DSBs generated as a result of 
collapsed replication forks which can occur due to DNA damage [37]. Following 
generation of a DSB, the HR machinery is recruited to repair the broken DNA sequence. 
 
Several models exist to explain repair of a DSB by HR including synthesis-dependent 
strand annealing (SDSA), double-strand break repair (DSBR), single-strand annealing 
(SSA), and break-induced replication (BIR) [39]. The SDSA and DSBR models follow 




but differ in the final product. In SDSA the result is a non-crossover event yielding a 
duplicated genetic sequence while in DSBR both non-crossovers as well as crossovers, in 
which the genetic sequence between the donor and corrected templates are swapped, can 
occur [42]. In SSA a DSB generated between direct repeats can be repaired by annealing 
between the repeat regions following resection, which results in loss of the intervening 
sequence [43]. BIR can be used to repair a DSB by copying the sequence from a 
homologous chromosome in a process which can extend all the way to the telomere, 
resulting in duplication of the copied chromosome end [44].  
 
Several key proteins are involved in repair via these HR pathways. The 
Mre11/Rad50/Xrs2 (Nbs1 in humans) (MRX) complex is involved in processing the 
break and generating 3’ overhangs following resection in a 5’ to 3’ manner [45]. The Rpa 
complex (Rfa1/Rfa2/Rfa3 in yeast; Rpa1/Rpa2/Rpa3 in humans) binds to the 3’ single-
stranded DNA (ssDNA) ends and prevents formation of secondary structures [41]. The 
Rad52 protein anneals complementary strands of ssDNA and mediates the loading of 
Rad51 to the resected 3’ ends of the DNA, while the Rad51 protein is a recombinase 
involved in the exchange between ssDNA and a double-stranded molecule [37]. In yeast, 
Rad55 and Rad57 aid in  the strand exchange initiated by Rad51, Rad54 is a chromatin 
remodeling factor which helps provide access to genomic regions, and Rad59 (a paralog 
of Rad52) is involved in gene conversion [42]. Other factors involved in one or more of 
these HR pathways include Sae2, Exo1, Dna2, and Sgs2, which have roles in 5’ end 
resection; and Rad1, Rad10, Msh2, and Msh3, which have roles in trimming non-




response factors, including ATM, in cells defective in telomerase and is highly-dependent 
on ATM and the human 53bp1, which is a protein involved in promoting end joining of 
damaged chromosome ends and which together prevent resection of the ends [46,47]. 
 
1.3 GENE TARGETING AND A DSB 
As gene targeting follows the steps of HR, it requires recruitment of the HR machinery to 
exchange the genetic sequences. However, HR is naturally inefficient in many cell types 
including human somatic cells, in which spontaneous recombination occurs at levels 
around 10
-6
 while random integration is ~1000-fold more efficient [48,49]. Because of 
these low levels, researchers have sought to activate HR in order for gene targeting to be 
considered a practical approach. The generation of a DSB has widely been used for this 
purpose as a DSB is the natural target of the HR machinery. 
 
1.3.1 A DSB can efficiently trigger HR at the site of the break 
Meganucleases are proteins with large (12-40 base pairs, bp) recognition sequences and 
which generate a DSB at a specific DNA site [50]. Numerous studies have shown that 
generating a site-directed DSB with a meganuclease such as I-SceI can stimulate HR up 
to 1,000-fold or more in yeast, human cells, zebrafish, Xenopus, and others [51-57]. 
Engineered “designer” nucleases, such as zinc finger nucleases (ZFNs) and transcription 
activator-like effector nucleases (TALENs), have also been shown to trigger the HR 
machinery efficiently [58-64]. In these systems, DNA binding domains can be directed to 
target a specific DNA sequence by fusing ZFs or TALEs with the catalytic domain of the 




integrase, which stimulates recombination at recognition sequences known as attachment 
(att) sites, have been used for targeted gene insertion within the genome of bacterial, 
yeast, and human cells [66-68]. Most recently, clustered regularly interspaced short 
palindromic repeat (CRISPR)/CRISPR associated (Cas) systems have been shown to 
function as genome-engineering tools based on DSBs mediated by interactions with 
guide ribonucleic acid (gRNA) [69,70]. 
 
1.3.2 Recombination at a distant locus following DSB generation 
Not only does generation of a DSB stimulate recombination at the site of the break, it can 
also stimulate recombination at sites distant from the break as has been demonstrated in 
yeast at distances up to 20 kb from the site of an I-SceI DSB [52].  Depending on the 
position of the DSB relative to the targeted gene, correction after break generation was 
observed up to 60-fold over levels without a break [52]. Additionally, a strand bias in the 
correcting template for the targeted gene was observed for cases in which ss 
oligonucleotides (oligos) were utilized as donor sequences [52]. Resection occurs 
following processing of a DSB for HR repair, and this should leave the strand 3’ of the 
break intact [45]. Because the bias observed was in favor of the template complementary 
to the 3’ end of the break, it was proposed that generation of the DSB followed by 
extensive resection stimulated a large window for recombination. While observed in 
yeast cells with the I-SceI nuclease, this approach of gene targeting distant from a DSB 
could also be applied to studies using other DSB-inducing systems in other cell types. For 
example, the optimal position for cleavage by designed nucleases such as ZFNs may be 




locus, however, gene targeting may still be accomplished if the break is able to activate 
large regions for recombination. 
 
1.3.3 A DSB can be highly threatening 
While a DSB can efficiently stimulate recombination, it can do so at high cost to genomic 
integrity. A single unrepaired DSB can lead to cell death [71]. In yeast HR is the major 
DSB-repair pathway, but in human cells the error-prone non-homologous end-joining 
(NHEJ) pathway predominates [72]. In this process, broken DNA ends can be ligated 
together following minimal processing. However, if multiple DSBs are generated the 
ends could be rejoined in such a way that genomic segments are lost or gross 
chromosomal rearrangements (GCRs) are formed [73]. This could occur even when using 
a nuclease with a specific recognition sequence due to the propensity for “off-target” 
recognition of a similar genomic locus, as has been demonstrated for meganucleases and 
designed nucleases alike [74-76]. In multiple studies NHEJ events have been observed to 
occur at higher rates than the desired targeted HR events, illustrating the need for safer 
mechanisms of stimulating recombination for gene targeting approaches [77,78].  
 
1.4 SINGLE-STRAND BREAKS (SSB) GENERATED BY NICKASES 
An SSB, or nick, is a lesion that occurs when one strand of a double-stranded DNA 
molecule is cleaved. SSBs can arise from DNA damage after exposure to reactive oxygen 
species (ROS), during replication and DNA repair, and following cleavage by a nickase 
[79,80]. Various studies have demonstrated that gene targeting can be efficiently 




[54,69,77,78,81-83]. However, speculation exists as to whether the SSB itself is enough 
to stimulate recombination or if it must first be converted to a DSB by the enzyme after 
prolonged incubation [84]. 
 
1.4.1 HR following generation of an SSB 
In early models for recombination an SSB was thought to be the triggering lesion for the 
recombination event [85,86]. Though the focus has since shifted to DSBs, the finding of 
several groups that generation of an SSB was followed by targeted gene correction 
indicated that an SSB could also stimulate HR, possibly as a DSB intermediate. SSBs 
have been implicated as the initiating factors during V(D)J recombination in human cells 
[87]. Likewise, SSBs created through adeno-associated virus (AAV) Rep proteins Rep78 
and Rep68 have been used to insert genetic sequences at the preferred integration site of 
AAV (AAVS1) on human chromosome 19 [88]. Studies in yeast have demonstrated that 
intra- and inter-chromosomal recombination increased following generation of an SSB by 
the Gene II nickase of the bacteriophage f1 [54,89]. Moreover, an engineered nicking 
variant of the I-AniI protein was shown to stimulate recombination at episomal and 
chromosomal loci in human embryonic kidney (HEK-293) T cells at up to 25% the 
efficiency of the I-AniI nuclease [81]. Most recently zinc finger nickases and 
CRISPR/Cas systems using nicking enzymes have proven to efficiently modify 
chromosomal regions in human cells [69,82,90].  
 
1.4.2 The genetics of SSB-induced recombination 




HR in a safer manner than a DSB [80,91]. Studies using a nicking variant of the I-AniI 
nuclease have demonstrated not only that recombination at a genomic locus in human 
cells increases following generation of an SSB but that there are less accompanying 
NHEJ events compared to when the corresponding DSB is generated by I-AniI [77,78]. 
While it is unclear whether the SSB itself initiated recombination or if it was first 
converted to a DSB, the initial presence of the SSB seemed to be less mutagenic to the 
cells as fewer erroneous events were detected [77,78]. In particular, the ratio of HR to 
NHEJ events was 50-fold greater following SSB generation than the ratio observed 
following DSB generation, indicating that an SSB could initiate targeted gene correction 
more safely than a DSB even despite lower overall levels of recombination [77].  These 
differences could be due to a diverse repair mechanism for a DSB arising from 
replication fork collapse compared to a DSB generated prior to replication [77]. These 
findings demonstrate that SSB generation could be a safer alternative for targeted gene 
correction strategies than those relying on formation of a DSB. 
 
1.5 USE OF DNA OLIGOS FOR DNA REPAIR AND MODIFICATION 
DNA oligos are short segments of deoxyribonucleotides which can be produced in vivo 
from the breakdown of larger molecules. They can also be synthesized commercially and 
are used for a variety of purposes including as primers during polymerase chain reaction 
(PCR) and DNA sequencing and as molecular probes [92-94]. Additionally, short (~20-
80 nucleotide, nt) synthetic DNA oligos have been used to modify genomic DNA in 




accomplished using oligos homologous to either side of the target locus such that the HR 
machinery can substitute the oligo sequence information into the genomic locus [101].  
 
While this approach can be applied to gene correction strategies, it is generally limited to 
loci presenting selectable phenotypes upon recombination. In yeast, the delitto perfetto 
system for site-directed mutagenesis provides a robust method for generating these types 
of mutations in two steps [102-104]. In the first step, a cassette containing two markers is 
inserted into the target locus, and upon integration recombinants can be selected for based 
on a phenotype provided by one of the markers. In the second step, the cassette is 
removed and can be replaced with a homologous template. Again a phenotype indicating 
recombination is used to select for gene correction. In mammalian cells, phenotypic 
selection is also commonly used to observe recombination at a natural or artificially-
created genomic locus [60,105]. 
 
1.6 NICKING VARIANTS OF NATURAL MEGANUCLEASES 
The monomeric S. cerevisiae I-SceI meganuclease is a member of a family of nucleases 
characterized by the LAGLIDADG amino acid sequence motif [106]. As a homing 
endonuclease, I-SceI catalyzes insertion of its genetic information into an allele lacking 
the gene but possessing the cognate recognition sequence of the enzyme  [107]. It 
accomplishes this by generating a DSB at its 18-bp recognition sequence, which is 
subsequently repaired by the HR machinery, during which time the gene is inserted 
[106]. Because of its specificity for the target sequence, I-SceI is routinely utilized for 




types, including mammalian cells [53,55-57,60]. However, because of the issues of off-
site targeting and illegitimate repair of a DSB, other avenues have been explored. Thus, 
scientists have focused their attention on generating variants of I-SceI and other homing 
endonucleases, including I-AniI and I-CreI, which could be used to develop highly-
specific nickases for gene targeting applications [81,108-110]. 
 
1.6.1 The I-AniI nickase 
The Aspergillus nidulans meganuclease I-AniI recognizes an asymmetric 19-bp target 
sequence [111]. A nicking variant was generated through inactivation of one of the active 
sites through a lysine to methionine substitution at residue 227 [81]. The I-AniI K227M 
nickase has been used for gene targeting approaches in human cells to demonstrate the 
capacity for I-AniI SSB-induced repair at episomal and chromosomal loci [77,78,81]. A 
catalytically dead mutant was also generated through an additional mutation at residue 
171 to generate the non-breaking K227M/Q171K variant [81]. Another nickase, I-AniI 
Q171K, demonstrated nicking activity but it was accompanied by subsequent DSB 
cleavage with extended incubation and thus was not used for additional studies [81]. 
 
1.6.2 The I-SceI nickase 
Nicking variants of the I-SceI meganuclease were generated previously by the Gimble 
laboratory at Purdue [108]. Like the I-AniI nickase, these variants were generated by 
substituting a nonpolar residue for an acidic conserved lysine adjacent to either active site 
(residues 122 and 223, respectively), thus destablizing coordination of ions in one of the 




protein demonstrated eventual cleavage on both strands, though at different rates – after 
20 minutes for K122I and after 4 hours for K223I – indicating that complete inactivation 
of double-stranded (ds) cleavage activity was not possible through mutation of either of 
the residues alone [108]. Additionally, a catalytically dead mutant (I-SceI D145A) was 
generated by substituting the aspartic acid at residue 145 with an alanine which was 
thought to abolish cleavage capacity due to a loss of coordination of metal ions essential 
for catalytic activity [108]. Despite the generation of these mutants and positive in vitro 
work, no in vivo findings demonstrating the capacity for I-SceI SSB-induced repair has 
been published. 
 
1.7 RESEARCH GOALS 
In order to test recombination at and distant from the site of an SSB or DSB in yeast and 
human cells, we devised three major aims for carrying out these studies. 
 
1.7.1 To develop systems for testing the recombination potential of DNA breaks induced 
by different I-SceI variants in yeast and human cells 
We sought to develop systems for testing recombination potential of different I-SceI 
nuclease variants in yeast and in human cells. Additionally, we planned to utilize 
synthetic DNA oligos as recombination templates in our systems. In order to directly 
compare the recombination potential of different I-SceI variants that could activate HR 
through generation of a break, we planned to develop isogenic strains in yeast and lines in 
human cells. In yeast we aimed to utilize the delitto perfetto approach for site-directed 




two-step process and can be customized for genetic manipulation at any desired locus 
using a variety of targeting templates. Recombination at disrupted genomic loci with the 
correcting sequence yields restoration of the gene which can be observed through growth 
on a selective medium. For construction of isogenic human cell lines, we planned to use 
episomal as well as chromosomal constructs to directly compare the recombination at a 
defined locus. In our human systems, recombination at a disrupted fluorescent protein 
gene locus with the correcting sequence yields restoration of the gene which can be 
observed through detection of fluorescence. These systems provide useful tools for 
testing recombination potential of breaks generated by different I-SceI nucleases and can 
be adapted for studies in which other break-inducing proteins are assayed. 
 
1.7.2 To demonstrate I-SceI SSB-induced recombination at the site of the break in vivo 
Following generation of our isogenic yeast strains and human cell lines, we sought to 
explore the capacity for and rules of I-SceI SSB-induced recombination using DNA 
oligos as repair templates. 
 
1.7.2.1 Testing I-SceI SSB-induced recombination in yeast 
An SSB has been demonstrated to stimulate targeted gene correction in multiple 
organisms when generated by various nickases. However, the mechanism by which a 
nick can stimulate recombination remains elusive. We planned to take advantage of a 
novel I-SceI nickase, which was previously characterized for its in vitro activity, to 
examine its recombination potential in vivo and to provide insights on the mechanism by 




S. cerevisiae in which we could directly compare I-SceI SSB- and DSB-induced 
recombination. We planned to use two systems: a direct repeat system for repair of the 
lesion at the LYS2 locus and a system using DNA oligos complementary to the region 
surrounding a break generated in the TRP5 gene and capable of restoring the sequence of 
the gene. Moreover, we aimed to explore the rules of I-SceI SSB-induced recombination 
including bias for a repair template, genetic requirements, and activity following arrest 
within the cell cycle. 
 
1.7.2.2 Testing I-SceI SSB-induced recombination in human cells 
We sought to test the recombination potential of the I-SceI nickase in episomal and 
chromosomal systems in HEK-293 cells to determine whether the resulting lesion was 
capable of stimulating HR in human cells. We planned to develop a system for detecting 
recombination at two reporter sequences (red fluorescent protein, RFP, and green 
fluorescent protein, GFP) using DNA oligo-mediated repair. We also aimed to utilize a 
monoclonal cell line containing a stably integrated non-functional GFP target locus to 
determine if an I-SceI SSB could trigger recombination on the chromosome. If 
successful, the findings of this study could improve gene targeting approaches by 
demonstrating the capacity for an I-SceI SSB to stimulate the HR machinery in a 
mammalian system. 
 
1.7.3 To test I-SceI SSB- and DSB-induced recombination at sites distant from the break 
An I-SceI DSB has previously been shown to efficiently stimulate recombination in yeast 




the capability of a DSB to evoke the same response in human cells and even less is 
known about the capacity for SSB-induced recombination at a distant locus. To 
understand if an I-SceI SSB can trigger recombination in yeast not only at the site but 
also distant from the site of the break in yeast, we planned to develop several constructs 
for testing this activity. These constructs include isogenic strains in which the cognate 
recognition sequence is inserted in either orientation 10 kb upstream or downstream from 
the genomic locus targeted for gene correction. We also planned to develop a system for 
detecting HR at distant loci (up to 2 kb away) in human cells following generation of an 
I-SceI DSB or SSB. This system includes a dual reporter (RFP and GFP) plasmid which 
can be used to assess distant modification at either reporter, eliminating the variability 






GENE KNOCKOUTS, IN VIVO SITE-DIRECTED MUTAGENESIS AND OTHER 
MODIFICATIONS USING THE DELITTO PERFETTO SYSTEM IN 
SACCHAROMYCES CEREVISIAE 
 
The procedures detailed in Chapter 2 are modified from a publication of the same title in 
the online Methods Navigator series [112]: 
Stuckey, S. and Storici, F. (2010) Gene Knockouts, in vivo Site-Directed Mutagenesis 
and Other Modifications Using the Delitto Perfetto System in Saccharomyces cerevisiae. 
Methods Navigator: Cookbook of Biomedical Labs. Online. 
 
2.1 PURPOSE 
Gene manipulation serves the purpose of providing a better understanding of the function 
of specific genes as well as for developing novel variants of the genes of interest. The 
generation of knockout genes, the alteration, depletion, or enhancement of a particular 
gene function through the generation of specific gene mutations, or the generation of 
random mutations in a gene are all essential processes for gene manipulation. The 
genome of the yeast Saccharomyces cerevisiae is relatively easy to modify, owing to its 
efficient HR system. Gene knockout can be a very simple, one step approach to eliminate 
a gene by substituting its DNA sequence with that of a genetic marker. Differently, 




gene with that of the mutated gene. Recombinant DNA can be created in vitro and then 
introduced into cells, most often exploiting the endogenous recombination system of the 
cells. However, unless the desired mutation gives a particular phenotype, a bottleneck of 
‘recombineering’ is the requirement of a selection system to identify the recombinant 
clones among those unmodified. Even in an organism like yeast where the level of HR is 
highly above the incidence of random integration, the frequency of homologous targeting 




 depending on the length of the homology used [113].  Thus, a 
selection system is always required to identify the targeted clones. Counterselectable 
markers such as URA3, LYS2, LYS5, MET15, and TRP1 [114-117] are widely utilized in 
yeast and can be recycled for additional usage in the same yeast strain. If the marker is 
not eliminated or it is popped out via site-specific recombination between direct repeats 
such as in the Flp/FRT or Cre/Lox systems, a heterologous sequence is left as a scar at 
the modified DNA [118,119]. The presence of such scars can threaten the genomic 
stability of the strain and/or limit the number of successive genetic manipulations for that 
strain. Here we provide a refined guide, optimized protocols, and tips for using the delitto 
perfetto approach for in vivo mutagenesis that combines the practicality of a general 
selection system with the versatility of synthetic oligos for targeting [102]. The delitto 
perfetto approach allows for generation of gene knockouts and almost any sort of 
mutation and genome rearrangement via HR. The technique for in vivo mutagenesis is 
designed for efficient and precise manipulation of yeast strains in a two-step process 







Delitto perfetto is an Italian idiom for ‘perfect murder’, referring to its capabilities in 
generating the mutation of a targeted sequence of genomic DNA through insertion and 
removal of two markers without leaving any trace of foreign DNA in the cells – the 
perfect deletion of this exogenous material [102]. Collectively these two markers are 
referred to as a CORE cassette, indicating the presence of both COunterselectable and 
REporter markers, and are housed on the CORE plasmids: pCORE, pCORE-UK, 
pCORE-UH, pCORE-Kp53, pCORE-Hp5, pGSKU and pGSHU (Table 2.1) [53,102-
104,120]. Two of these, pGSKU and pGSHU, are referred to as the break-mediated 
system plasmids. In addition to the COunterselectable and a REporter markers, they also 
contain the gene for the I-SceI site-specific endonuclease under regulation of the 
galactose inducible promoter (GAL1 promoter) [53]. Taking into account the background 
of the starting strain, a CORE plasmid must first be selected from one of the seven 
available. Prior to introducing the chosen CORE cassette into the starting strain, 
polymerase chain reaction (PCR) is used to amplify the cassette from its respective 
plasmid. These primers should also be designed such that the tails contain 50 bases of 
homology upstream and downstream to the targeted genomic sequence for efficient 
integration.  
 
Examples of genetic modifications that are possible using the delitto perfetto approach 
are shown here. 







Table 2.1 CORE Cassette Composition and Primers Used for Amplification 
1
Two systems exist for use in the delitto perfetto in vivo site-specific mutagenesis technique: the non-break and break-
induced systems. 
2
Seven CORE plasmids are available for use.  
3
The sizes of the cassettes vary depending on the 
markers contained within that cassette. 
4
Each cassette contains one COunterselectable and one REporter marker. The 
break-mediated system plasmids additionally contain the regulatable GAL1 promoter and I-SceI gene. 
5
The sequence of 
primer needed to amplify each of the CORE cassettes is provided. The plasmids in the break-mediated systems require 
the addition of the 18 bp I-SceI recognition site (bold) next to the GAL1 promoter. In addition, researchers must include 




















P.1 5' - . . .GAGCTCGTTTTCGACACTGG  







P.I 5' - . . .TTCGTACGCTGCAGGTCGAC 







P.I 5' - . . .TTCGTACGCTGCAGGTCGAC 







P.I 5' - . . .TTCGTACGCTGCAGGTCGAC 







P.I 5' - . . .TTCGTACGCTGCAGGTCGAC 










P.I 5' - . . .TTCGTACGCTGCAGGTCGAC 
P.IIS 







P.I 5' - . . .TTCGTACGCTGCAGGTCGAC 
P.IIS 





or deletions can be created through the use of a single or complementary oligo(s) 
as small as 40 bp in length (20 bp of homology to either side of the target region, 
although the total length is preferably longer) [104]. 
 Random Mutations: Random mutations can be introduced at specific genetic loci, 
simply by designing oligos with degenerate base sequences that are used to pop-
out the CORE cassette previously integrated at the desired location. 
 Large In/Dels: Larger insertions or deletions can be accomplished through either 
removal of the CORE with oligo(s) or with a PCR-amplified region of DNA 
containing tails of homology to the target site. These inserted or deleted 
sequences can be used, for example, to create gene knockouts or replacements on 
a particular chromosome and rely on the break-mediated system CORE cassettes 
for high efficiency of gene modification. 
 Gene Collage: Gene collage is a term we use for the in vivo recombination of 
several segments of a gene or genes and their integration at the chosen locus 
following the delitto perfetto technique. For example, a selected gene and chosen 
promoter and terminator sequences can be amplified with primers through the use 
of PCR to contain regions of homology to each other as well as the target site. Co-
transformation of these pieces allows for recombination to yield one continuous 
segment within any specified site [120]. 
 Rearrangements: Gross chromosomal rearrangements (GCR) can be generated 
precisely by exploiting the break-mediated delitto perfetto approach. These 





The principle behind the effectiveness of delitto perfetto is the utilization of the yeast’s 
HR machinery [52,53,102]. Once the CORE cassette PCR product is inside the cells, the 
50 bp tails of homology attached during PCR amplification drive the sequence to the 
specified chromosomal locus with a frequency of about one targeted cell per 10
6
 cells. 
The resulting integration yields antibiotic resistance as well as provides a marker which 
can later be used for counterselection. For the plasmids used in the non-break system, 
these counterselectable markers are either the URA3 homolog KlURA3 from 
Kluveromyces lactis, which can be selected against using media containing 5-fluoroorotic 
acid (5-FOA), or the cDNA of human p53 mutant V122A, which can be selected against 
using galactose-containing media as it is toxic to yeast when overexpressed 
[103,104,120,121]. Antibiotic resistance is conferred by either the hyg (for Hygromycin 
B) or kanMX4 (for Geneticin, or G418) markers [113,122]. Additionally, the plasmids in 
the break-mediated system contain the galactose-inducible GAL1 promoter and the I-SceI 
gene, which, when expressed, generates a DSB at its 18-bp recognition site that is 
inserted into the chosen genomic site with one of the primers used for the PCR 
amplification of the CORE [53] (see Table 1). A DSB at this site is utilized only in the 
second step of delitto perfetto to stimulate HR and increase the targeting efficiency more 
than 1,000 fold [52,53,104]. An example of the overall scheme using the break-mediated 
CORE plasmid pGSKU illustrates the generation of both a knockout of a chosen gene 







Figure 2.1. The two-step process of delitto perfetto to generate a gene knockout or 
gene mutation. The starting strain, containing a normal copy of your favorite gene 
(YFG), is illustrated at the top of the figure. The first step involves insertion of a CORE 
cassette (GSKU, using the break-mediated system, is shown here), which is first PCR 
amplified from the chosen CORE plasmid (pGSKU here). This PCR product contains at 
least 50 nucleotides of homology to either side of the targeted region, thereby allowing 
for efficient recombination and integration at this locus. The second step involves 
removal of the cassette to generate the desired mutation. Here, the induction of a DSB at 
the I-SceI site following the addition of galactose to the media stimulates recombination 
and drives the targeting molecules (complementary oligos) to either completely remove 





For successful utilization of the delitto perfetto technique, several points must be 
considered. 
 One crucial factor in the delitto perfetto method for in vivo mutagenesis is 
working with single-colony isolates in each step of the process. Single-colony 
isolates are obtained by streaking cells from the initial strain and successively 
transformant colonies on the YPD rich growth media (recipe below). Once the 
single-colony isolates are obtained (after 2 days of growth on YPD), these are 
patched on the YPD for temporary storage, phenotypic and colony PCR testing. If 
the working strains do not come from single-colony isolates, the subsequent 
transformation results will be flawed due to a mixed population of cells.  
 The delitto perfetto approach is designed to be used on haploid strains of yeast. In 
diploid strains, oligo targeting has diminished capabilities for recombination with 
the targeted chromosome since it is competing with the gene conversion activity 
from the homologous chromosome, which is ~250 fold more efficient. However, 
it is possible to use the delitto perfetto technique also in diploid strains, but 
through a more labor-intensive colony-PCR screening process [104]. 
 The frequency of spontaneous mutation in the KlURA3 or the p53 allele is similar 
to the frequency of CORE pop-out by oligos. However, the delitto perfetto 
approach is designed to circumvent this issue by exploiting the use of the reporter 
marker. Since the likelihood of spontaneous mutation in both the 
counterselectable and the reporter markers is very low (expectedly ~1/10
12
), cells 
that are deficient for both markers of the CORE following phenotypic test in 




 When the KlURA3 gene is inserted in such a way that it receives interference from 
another gene’s promoter, there may be a delay in growth on media lacking uracil 
when first inserting the marker or a high level of background when selecting 
against its function through removal of the marker. This phenomenon, called 
promoter occlusion (or transcriptional interference), can be resolved through the 
insertion of KlURA3 in the orientation opposite that of the conflicting promoter 
[104].  
 Once a CORE cassette is inserted in a chosen chromosomal location, many 
different mutations can be generated at that locus or in its vicinity, simply by 





Microcentrifuges (with 7 cm radius for 1.5-ml tubes and 15 cm radius for 50-ml tubes) 
PCR thermocycler 
Agarose gel electrophoresis equipment 












1.5-ml microcentrifuge tubes 
50-ml conical tubes 
250-ml Erlenmeyer flasks 
100 × 15 mm Petri dishes 
Glass beads 




DNA primers for PCR 
DNA oligos for transformation 
Agarose 
Tris base 
Boric acid (H3BO3) 
EDTA 
Prestained DNA ladder 
6× DNA loading dye 
Ethanol (95% and 70%) 











Yeast nitrogen base (without amino acids and ammonium sulfate) 




Lithium acetate (LiOAc) 
Polyethylene glycol 4000 (PEG 4000) 
Salmon sperm DNA (SSD) 
Geneticin (G418) 
Hygromycin B (Hygro) 
5-Fluoroorotic acid (5-FOA) 
Sterile deionized water 
Lyticase 
Ex Taq DNA polymerase, 10× buffer (Mg
2+
) 








2.5 SOLUTIONS AND BUFFERS 
STEP 2.5.2  
Table 2.2 Preparation of 10x TBE 
Dissolve Tris and boric acid in ~ 750 ml of deionized water. Add EDTA. Adjust final 
volume to 1000 ml with water. There is no need to adjust the pH of this solution. 
Dilute 50 ml 10× TBE in 950 ml H2O to make 0.5× TBE. 
 
Component  Final concentration  Stock  Amount 
Tris base  100 mM   N/A  108 g 
EDTA, pH 8.0  1x    0.5 M  40 ml 




Table 2.3 Preparation of 3 M NaOAc, pH 5.2 
Filter sterilize.  
 




Table 2.4 Preparation of Solution 1 
Add water to 10 ml. 
 
Component  Final concentration  Stock  Amount 
LiOAc   100 mM   1 M  1 ml 








Table 2.5 Preparation of Solution 2 
Add 50% PEG 4000 – 10 ml. 
 
Component  Final concentration  Stock  Amount 
LiOAc   100 mM   1 M  1 ml 
TE, pH 7.5  1x    10x  1 ml 
 
 
Table 2.6 Preparation of YPD liquid medium 
Add water to 1 l. Sterilize by autoclaving. 
 
Component  Final concentration  Amount 
Yeast extract  1%    10 g 
Soy peptone  2%    20 g 
Dextrose  2%    20 g 
 
 
Table 2.7 Preparation of YPD solid medium 
Add water to 1 l. Sterilize by autoclaving and pour plates when slightly cooled. 
 
Component  Final concentration  Amount 
Yeast extract  1%    10 g 
Soy peptone  2%    20 g 
Dextrose  2%    20 g 










Table 2.8 Preparation of YPG solid medium 
Add water to 1 l. Sterilize by autoclaving and pour plates when slightly cooled. 
 
Component  Final concentration  Amount 
Yeast extract  1%    10 g 
Soy peptone  2%    20 g 
Glycerol  3%    30 ml 
Agar   2%    20 g 
 
 
Preparation of YPD solid medium containing G418 
Prepare 1 l YPD solid medium and sterilize by autoclaving. After the medium has cooled 
to ~55-60 °C, add 4 ml of 50 mg/ml G418 solution for a final concentration of 200 µg/ml. 
Pour plates. 
 
Preparation of YPD solid medium containing Hygromycin B 
Prepare 1 l YPD solid medium and sterilize by autoclaving. After the medium has cooled 
to ~55-60 °C, add 6 ml of 50 mg/ml Hygromycin B solution for a final concentration of 
300 µg/ml. Pour plates. 
 
Preparation of YPGal solid medium 
Prepare 900 ml of YPD w/o glucose medium and sterilize by autoclaving. Separately, 
dissolve 20 g galactose in 100 ml sterile water and filter sterilize. After the medium has 
cooled to ~55-60 °C, slowly add 100 ml of galactose 20% solution for a final 




Table 2.9 Preparation of Synthetic Complete (SC) – Ura solid medium 
Add water to 1 l. Sterilize by autoclaving and pour plates when slightly cooled. 
* (See [123] for composition in medium) 
 
Component  Final concentration  Amount 
Yeast nitrogen base 0.17%    1.7 g 
Ammonium sulfate 0.5%    5 g 
Dextrose  2%    20 g 
Agar   2%    20 g 
Amino and nucleic acids*: L-Tryptophan, L-Histidine hydrochloride, L-Arginine 
hydrochloride, L-Methionine, L-Tyrosine, L-Leucine, L-Isoleucine, L-Lysine 
hydrochloride, L-Phenylalanine, L-Glutamic acid, L-Aspartic acid, L-Valine, L-
Threonine, L-Serine, Adenine sulfate. 
 
 
Preparation of Synthetic Complete solid medium containing 5-FOA 
Prepare 700 ml of Synthetic Complete medium and sterilize by autoclaving. Separately, 
dissolve 1 g 5-FOA in 300 ml sterile water and filter sterilize. After the medium has 











Table 2.10 Preparation of YPLac liquid medium 
Add water to 1 l. Adjust pH to 5.5 with lactic acid. Sterilize by autoclaving. 
 
Component  Final concentration  Amount 
Yeast extract  1%    10 g 
Soy peptone  2%    20 g 
Lactic acid  2.7%    27 ml 
 
 
Preparation of YPLac overnight (O/N) culture containing galactose 
Add 5 ml of the 20% galactose solution to 50 ml YPLac O/N culture to give a final 
concentration of 2%. 




 Prepare all media beforehand (see [123]). It is recommended to check starting 
strain’s phenotype prior to transformation. 
 Based on the background of the starting strain, select the CORE plasmid to be 
used. Order DNA primers to amplify the chosen CORE cassette (Table 2.1) with 
tails of homology to either side of the target site. 
 Depending on the desired modification, order DNA oligo(s) containing the 




homology to either side of the target site. 
 Sterilize water and velveteen squares (for replica-plating) by autoclaving. 
 
STEP 2.6.1: PCR AMPLIFICATION OF THE CORE CASSETTE 
Upon determining the desired mutation(s) to be made, the researcher must select a CORE 
cassette and amplify it from the plasmid using the DNA primer sequences provided in 
Table 2.1. The primers should also contain 50 bases of homology to either side of the 
target locus for efficient targeting and recombination. The use of the break-mediated 
system in the delitto perfetto technique allows for an increased efficiency of targeting 
(more than 1,000 fold), thus providing more applications for the mutagenesis system. 
However, the generation of a DSB is not always preferred; therefore, the plasmids for the 
non-break system may be more suitable. 
1. Determine the CORE cassette needed based on the background of the original  
    strain. 
2. Perform PCR on the sample using Ex Taq DNA polymerase and its provided   
    buffer and dNTP mix. Add to a thin-walled PCR tube: 
CORE plasmid (100 ng/μl) (0.5 μl), DNA primers (50 pmol/μl) (1 μl 
(each)), 10x Ex Taq buffer (4 μl), dNTP mix (2.5 mM) (4 μl), Ex Taq 
polymerase (5 U/μl) (0.2 μl), Water (to 40 μl) 






1 cycle of 
94 °C  2 min 
32 cycles of 
94 °C  30 s 
57 °C  30 s 
72 °C  4 min (5 min for cassettes over 4 kb in size) 
1 cycle of 
72 °C  7 min 
1 cycle of 
4 °C  hold 
 
Tip 
Set up six reactions so there will be enough of the PCR product for later steps. 
 
STEP 2.6.2: AGAROSE GEL ELECTROPHORESIS TO VISULAIZE THE PRODUCT 
OF PCR 
Following PCR, the product must be visualized by agarose gel electrophoresis to ensure 
that amplification occurred using the DNA primers. 
1. Pour a 0.8% agarose gel in 1× TBE. 
2. Mix 2 μl of PCR product with 1 μl 6× DNA loading dye and 3 μl water. Load    
    on gel along with a prestained DNA marker. 




4. If the PCR product is clean, combine the samples to concentrate the PCR  
    product. If there are multiple bands, run the remaining reaction on a gel and  
    purify the correctly sized band. 
 
STEP 2.6.3: CONCENTRATION OF THE PCR PRODUCT 
Concentrating the product is necessary prior to transformation into the cells. In this step, 
you will precipitate the PCR product using ethanol and sodium acetate followed by 
drying the pellet in a speed vac. 
1. Combine the six reactions of PCR in a 1.5-ml microcentrifuge tube. Add  
      2.5 volumes of 95% ethanol and 0.1 volumes of 3 M NaOAc (pH 5.2). 
2. Centrifuge the tube at 13 000 rpm for 10 min. A small pellet should be   
     visible at the bottom of the tube following centrifugation. 
3. Discard the supernatant and wash the pellet with 100 μl 70% ethanol   
     without disturbing the pellet. Centrifuge the tube at 13 000 rpm for 5 min  
     and discard the supernatant only. Remove as much ethanol as possible. 
4. Dry the pellet in a speed-vac for about 15 min, or until it is completely   
     dry. Resuspend the pellet in 50 μl of water. Five to ten microliters will be  
     used for each transformation. 
 
STEP 2.6.4: INSERTION OF THE CORE CASSETTE INTO THE CHOSEN GENETIC 
LOCUS 
The first step in delitto perfetto in vivo mutagenesis involves insertion of the PCR-




transformation of cells with the PCR product and recombination of the CORE cassette 
with the cells’ genomic DNA. The following transformation uses a procedure modified 
from the lithium acetate (LiOAc) protocol described by Wach, et al. [113]. For this 
procedure, LiOAc will be used to make the cells permeable while PEG 4000 is used to 
adhere the DNA to the cells such that the proximity will optimize the potential entry into 
the cells. Salmon sperm DNA (SSD) is used to act as carrier DNA and allow the targeting 
DNA of the PCR product to be protected from DNA degradation factors within the cell. 
1. Inoculate 5 ml of YPD liquid medium with the chosen strain and shake (~ 200  
    rpm) at 30 °C overnight (O/N). 
2. Inoculate 50 ml of fresh YPD liquid medium with 1.5 ml of the O/N culture in  
    a 250-ml glass flask and shake vigorously at 30 °C for 3 h. 
3. Prepare Solution 1 and Solution 2 immediately prior to transformation. Heat- 
    denature the SSD at 100 °C for 5 min and immediately put on ice prior to  
    transformation. 
4. Transfer the culture to a 50-ml conical tube and spin at 3000 rpm for 2 min. 
5. Discard the supernatant and wash the cells with 50 ml of sterile water. Spin at  
    3000 rpm for 2 min. 
6. Discard the supernatant and resuspend the cells in 5 ml of Solution 1. Spin at  
    3000 rpm for 2 min. 
7. Discard the supernatant and resuspend the cells in 250 µl of Solution 1. This  
    amount of cells is sufficient for about seven to eight transformations. 
8. Aliquot 50 µl of the cell suspension into 1.5-ml microcentrifuge tubes and add  




    denatured SSD to each tube. Gently mix by tapping the tube. 
9. Add 300 µl of Solution 2 for each transformation reaction and mix briefly by  
    vortexing. 
10. Incubate the transformation reactions at 30 °C for 30 min at ~ 200 rpm. 
11. Heat-shock the cells at 42 °C for 15 min to drive the DNA into the cells. 
12. Collect the cells by centrifugation at 5000 rpm for 4 min. 
13. Remove the supernatant and resuspend the cells in 100 µl of water. 
14. Plate the entire transformation mix onto one SC-Ura plate using ~ 8-12 sterile 
      glass beads. Remove the beads when the plate is dry and incubate at 30 °C for  
      2-3 days. 
15. After colonies are visualized, replica-plate from SC-Ura to G418- or Hygro- 
      containing media (depending on the CORE used) using a sterile velveteen  
      square and incubate at 30 °C O/N. 
16. Typically about 5-30 colonies per plate will be observed on the antibiotic- 
      containing media. Streak several for single colony isolates on YPD solid  
       media. Incubate at 30 °C for 2 days. 
17. Patch the original strain and the single colonies to new YPD solid media. 
      Incubate at 30 °C O/N. 
18. Replica-plate the grown patches to YPD, SC-Ura, G418 or Hygro, YPG (to  
       select against petite cells which are defective in mitochondrial DNA), and  
       any other various selective media depending on the background of your  
       strain. Incubate at 30 °C O/N. 




      for genotypic testing. 
 
Tip  
When using the CORE plasmids containing KlURA3, if the point of insertion for the 
marker places it in the same orientation as the targeted gene there may be delay in growth 
on the SC-Ura media. This is due to interference from the disrupted gene’s promoter 
during transcription. For this reason, it is optimal to insert the cassette such that the 
insertion of KlURA3 is oriented opposite to the direction of the gene. 
 
Tip  
If delayed growth on SC-Ura media is observed, redo the transformation and instead plate 
to YPD solid media. Then, replica-plate the G418- or Hygro-containing media the 




S. cerevisiae is an aerobic species, so do not cap lids tightly when incubating the O/N 
culture. Instead, loosely place the lid on and tape it down to secure it. 
 
Tip 
Each transformation reaction will require ~6 ml of Solution 1 and 300 µl Solution 2. 








The yeast cells will be very difficult to resuspend after the final centrifugation prior to 
plating.  First, pipette the cells to detach them from the tube, then vortex the mixture. 
 
STEP 2.6.5: COLONY PCR OF THE TRANSFORMANTS  
Following transformation of the CORE PCR product into the cells and correct phenotypic 
observation, colony PCR is necessary to observe the correct insertion of the CORE into 
the desired locus. Primer pairs should include one primer internal to the CORE and one 
primer external in the target sequence for both markers. Additionally, internal primers of 
the gene should be paired with its external primers to verify disruption of the gene [120]. 
1. Resuspend the cells (from a colony about 1 mm
3
) in 50 µl of water containing 1 
    unit of lyticase. 
2. Incubate the cells at room temperature for 10 min. 
3. Incubate the cells in a heat block at 100 °C for 5 min. 
4. Set up PCR. Add to a 0.5-ml thin-walled PCR tube: 
Cell solution (10 μl), Primers (50 pmol/μl) (1 μl (each)), 10x Taq buffer (5 
μl), dNTP mix (10 mM) (1 μl), Taq polymerase (5 U/μl) (0.2 μl), Water 
(to 50 μl) 




1 cycle of 
95 °C  2 min 
32 cycles of 
95 °C  30 s 
55 °C  30 s 
72 °C  1 min (1 min per kb) 
1 cycle of 
72 °C  7 min 
1 cycle of 
4 °C  hold 
6. Pour a 1% agarose gel in 1× TBE. Run samples at 100 V for ~ 30 min. 
    Visualize the PCR product using a UV transilluminator. 
7. Samples are now ready to remove the CORE. 
  
Tip  
The antibiotic resistance and Ura
+
 phenotype of the strain following transformation with 
the CORE PCR product coupled with the correct colony PCR results provide sufficient 
evidence for correct insertion at the desired locus. Therefore, it is not necessary to 
perform sequencing analysis for this part of the delitto perfetto technique. 
 
Tip 
Other digestive enzymes may be used to degrade the thick yeast cell wall, including 




STEP 2.6.6: TRANSFORMATION USING DNA OLIGOS TO GENERATE THE 
DESIRED MUTATION(S) 
The second step in delitto perfetto involves removal of the CORE cassette and generation 
of the desired mutation(s). This is accomplished through recombination of a variety of 
substrates with the cells’ genomic DNA. These include a single or pair of complementary 
oligo(s) containing the mutation(s) or a PCR product. Again, the regions of homology to 
either side of the target locus drive the removal of the CORE and integration of the 
targeting DNA. For the following procedure, the mutation is created via transformation 
by DNA oligo(s), which act as carrier themselves at the concentration of 1 nmole/20 μl, 
thus the use of SSD is unnecessary. 
1.a For the non-break system, inoculate 5 ml of YPD liquid medium with the  
     chosen strain and shake (~200 rpm) at 30 °C O/N. 
1.b For the break-mediated system, inoculate 50 ml of YPLac liquid medium with  
      the chosen strain in a 250-ml glass flask and shake (~200 rpm) at 30 °C O/N  
      (~ 18-20 h). 
2.a For the non-break system, inoculate 50 ml of fresh YPD liquid medium with  
      1.5 ml of the O/N culture in a 250-ml glass flask and shake vigorously at  
      30°C for 3 h. 
2.b For the break-mediated system, add 5 ml of 20% galactose to the O/N culture  
    and shake vigorously at 30 °C for 3 h. 
3. Prepare Solution 1 and Solution 2 immediately prior to transformation. Heat- 
    denature the chosen oligo(s) at 100 °C for 2 min and immediately put  




4. Transfer the culture to a 50-ml conical tube and spin at 3000 rpm for 2 min. 
5. Discard the supernatant and wash the cells with 50 ml of sterile water. Spin at  
    3000 rpm for 2 min. 
6. Discard the supernatant and resuspend the cells in 5 ml of Solution 1. Spin at 
    3000 rpm for 2 min. 
7. Discard the supernatant and resuspend the cells in 250 µl of Solution 1. This  
    provides enough cells is for about seven to eight transformations. 
8. Aliquot 50 µl of the cell suspension into 1.5-ml microcentrifuge tubes and add  
    20 µl of oligo(s) (1 nmol). Gently mix by tapping the tube. 
9. Add 300 µl of Solution 2 for each transformation reaction and mix briefly by  
    vortexing. 
10. Incubate the transformation reactions at 30 °C for 30 min, shaking at ~200  
      rpm. 
11. Heat-shock the cells at 42 °C for 15 min to drive the DNA into the cells. 
12. Collect the cells by centrifugation at 5000 rpm for 4 min. 
13. Remove the supernatant and thoroughly resuspend the cells in 100 µl of water. 
14.a For the non-break system, plate all cells from each transformation tube on  
       one YPD plate using ~ 8-12 sterile glass beads. Remove the beads when the 
       plate is dry and incubate at 30 °C O/N. 
14.b For the break-mediated system, dilute cells either 100-, or 1,000-, or 10,000-  
       fold from each transformation tube and plate on a YPD plate using ~8-12  
       sterile glass beads. Remove the beads when the plate is dry and incubate at  




15. Using sterile velveteen, replica-plate from YPD to 5-FOA or YPGal (if using  
      CORE-Kp53 or CORE-Hp53) and incubate at 30 °C for 2 days. If necessary,  
       replica-plate again on 5-FOA or YPGal medium to allow for growth of ura3  
       colonies or p53-less colonies, respectively. 
16. After visualizing colonies, replica-plate from 5-FOA or YPGal to YPD and  
      G418- or Hygro-containing media (depending on the CORE used) and  
      incubate at 30 °C O/N. 
17. Mark the G418-sensitive or Hygro-sensitive colonies on the YPD media and  
       streak several for single colonies on new YPD solid media. Incubate at 30 °C  
       for 2 days.  
18. Patch the original strain and the single colonies to new YPD solid media.  
      Incubate at 30 °C O/N.  
19. Replica-plate the grown patches to YPD, SC-Ura, G418 or Hygro, YPG (to  
       select against petite cells which are defective in mitochondrial DNA), and  
       any other various selective media depending on the background of your  
       strain. Incubate at 30 °C O/N. 
20. Following observation of the correct phenotype, the samples are now ready  
      for genotypic testing using the procedures described in Step 5. 
21. PCR samples containing the mutagenized region are now ready for DNA  
       purification and sequencing analysis. 
 
Tip  




be seen on 5-FOA media when removing the CORE. A second round of replica-plating to 
this media, however, will sufficiently remove these excess cells.  
 
Tip 
S. cerevisiae is an aerobic species, so do not cap lids tightly when incubating the O/N 




When using the break-mediated system, inoculation into YPLac allows the cells to grow 
in a neutral carbon source medium prior to the addition of galactose. However, the cells 
will grow much slower so it is suggested that the O/N culture be inoculated in YPLac at 
least 18-20 h prior to the addition of galactose. 
 
Tip 
Each transformation reaction will require ~6 ml of Solution 1 and 300 µl Solution 2. 
Therefore, it is important to determine the number of transformations being performed 




The yeast cells will be very difficult to resuspend after the final centrifugation prior to 





The efficiency of the break-mediated system is much greater; therefore, dilute the cells 
prior to plating. The efficiency depends on the modification performed and on the 








IN VIVO SITE-SPECIFIC MUTAGENESIS AND GENE COLLAGE USING THE 
DELITTO PERFETTO SYSTEM IN YEAST SACCHAROMYCES CEREVISIAE 
 
The procedures detailed in Chapter 3 are modified from a publication of the same title in 
the Methods in Molecular Biology book series, DNA Recombination edition [120]: 
Stuckey, S., Mukherjee, K., and Storici, F. (2011). School of Biology, Georgia Institute 
of Technology, Atlanta, GA. Meth Mol Biol. 745:173-192. 
 
3.1 ABSTRACT 
Delitto perfetto is a site-specific in vivo mutagenesis system that has been developed to 
generate changes at will in the genome of the yeast Saccharomyces cerevisiae. Using this 
technique, it is possible to rapidly and efficiently engineer yeast strains without requiring 
several intermediate steps as it functions in only two steps, both of which rely on HR to 
drive the changes to the target DNA region. The first step involves the insertion of a 
cassette containing two markers at or near the locus to be altered. The second step 
involves complete removal of this cassette with oligos and/or other genetic material and 
transfer of the expected genetic modification(s) to the chosen DNA locus. Here we 




most common and useful applications for in vivo mutagenesis to generate base 
substitutions, deletions, insertions, as well as for precise in vivo assembly and integration 




The yeast Saccharomyces cerevisiae is the most well characterized eukaryotic organism 
as it has been long utilized for brewing and baking as well as being very easy to grow and 
manipulate in the laboratory [123]. S. cerevisiae was the first eukaryote to have the 
complete genome sequenced [124], and the genome sequencing project led to the 
discovery of many new yeast genes with unknown function [125,126]. Moreover, as an 
‘honorary mammal’, S. cerevisiae has a large number of genes that are homologs of 
mammalian and human genes [127]. Thus, functional analysis studies in the yeast model 
organism shed light on the roles of the corresponding genes in humans and in many other 
higher eukaryotes. Beyond the simplest experiments of gene disruption or gene knockout, 
where the original sequence of a gene is replaced with that of a genetic marker [113], 
site-specific mutagenesis of the genes of interest is the most powerful approach of reverse 
genetics to reveal what phenotypes arise as a result of the presence of particular genes 
and to generate novel variants of the genes. Thus, the possibility to generate specific 
point mutations or localized random changes at will, directly in vivo in the DNA locus of 
choice without leaving behind any marker or other heterologous DNA sequence, provides 
the opportunity to better understand and modify the role of a given genetic element, or 




‘perfect murder’, the delitto perfetto (Italian for perfect murder) approach to in vivo 
mutagenesis utilizes simple, precise and highly efficient tools for engineering the genome 
of yeast cells with the desired modifications [102,103]. Exploiting the tremendous 
capacity of S. cerevisiae to perform efficient HR even when very short regions of 
homology are involved (30-50 bp) [113], synthetic oligos represent the most versatile and 
high-throughput device for genome engineering in a homology-driven manner [103]. 
Moreover, taking advantage of the fact that a DSB stimulates HR 1,000-10,000 fold, 
using the break-mediated delitto perfetto system, it is possible to simultaneously generate 
multiple different mutants or perform more sophisticated genetic rearrangements that 
would otherwise be too rare to be detected [52,53,104]. 
 
The first step of delitto perfetto involves the insertion of a COunterselectable REporter 
(CORE) cassette containing two markers. Prior to initiating this step the researcher must 
decide which CORE cassette to use, taking into account the background of the strain (See 
Note 3.7.1) to be mutagenized, the markers currently present within this strain and the 
kind of mutation(s) desired. Seven CORE plasmids have been created (Figure 3.1), 
including those for a non-break system and break system, thereby providing the 
researcher various choices to utilize this technique.  
 
Amplification of the chosen CORE cassette from its respective plasmid by polymerase 
chain reaction (PCR) is accomplished using primers which also contain 50-bp tails of 






Figure 3.1 The CORE plasmids used in the delitto perfetto technique. Each of the five 
plasmids used in the non-break system (a) contains a counterselectable marker, either 
KlURA3 from Kluyveromyces lactis or a mutant form (V122A) of the human p53 cDNA, 
and a reporter marker, either kanMX4 conveying resistance to Geneticin (G418) or hyg 
for resistance to the antibiotic hygromycin B. In addition to these markers, the two 
plasmids used in the break system (b) contain the inducible GAL1 promoter and I-SceI 
gene used to express the I-SceI endonuclease and generate a DSB at the I-SceI site. The 
origin of replication (ori) for all CORE plasmids is indicated as well as the bla marker 















Table 3.1 Primers for CORE Cassette Amplification and Verification of CORE Cassette Insertion 
a
There are seven CORE plasmids available. 
b
Amplification of the plasmids by PCR can be accomplished by creating primers 
with the above-listed sequences that are  internal to the CORE and an external region homologous to the region in which the 
CORE will be inserted. The primers used to amplify the cassettes from pGSKU and pGSHU require the addition of the 18-bp 
I-SceI recognition site (bold) next to the GAL1 promoter.  
c
The sizes and composition of the cassettes vary depending on the 
markers present. 
d
Primers and their sequences used for verification of CORE integration and replacement are provided. 
Sequences of primers for testing: GalE (5’ - CTAAGATAATGGGGCTCTTT); H1 (5’ - 
CCATGGCCTCCGCGACCGGCTGC); K1 (5’ - TACAATCGATAGATTGTCGCAC); K2 (5’ - 
AGTCGTCACTCATGGTGATT); p53.2 (5’ – GACTGTACCACCATCCACT); URA3.1 (5’ - 
TTCAATAGCTCATCAGTCGA); URA3.2 (5’ - AGACGACAAAGGCGATGCAT) 
PLASMID
a














5' - . . .GAGCTCGTTTTCGACACTGG 











5' - . . .TTCGTACGCTGCAGGTCGAC 











5' - . . .TTCGTACGCTGCAGGTCGAC 












5' - . . .TTCGTACGCTGCAGGTCGAC 











5' - . . .TTCGTACGCTGCAGGTCGAC 

















5' - . . .TTCGTACGCTGCAGGTCGAC 












5' - . . .TTCGTACGCTGCAGGTCGAC 













Figure 3.2 The two-step process of delitto perfetto. (a) Step one involves the 
amplification of a CORE cassette by PCR (portions of primers used for amplification 
indicated by thinner line and arrow). (b) The primers create tails of homology to either 
side of the target region (indicated by thicker line) for integration into the genome using 
the cell’s homologous recombination machinery. In this example, the use of the break 
system CORE cassette GSHU is illustrated. Note that the primer amplifying from the 
GAL1-I-SceI side of the cassette introduces the 18-bp I-SceI recognition site (black box). 
This site is utilized in the second step (c) when the I-SceI endonuclease expression is 
turned on with galactose to generate a DSB prior to replacement of the CORE with an 
oligo sequence, which introduces the desired mutation. This example uses a single-
stranded oligo to enact this change; however, a pair of complementary oligos has been 





integration of the CORE to its desired location (Figure 3.2B) in the first step of delitto 
perfetto. The second step involves replacement of the entire cassette with oligos or larger 
pieces of DNA to yield the expected modification to the original segment of 
chromosomal DNA (Figure 3.2C). The generation of a DSB next to the CORE in the 
break system enhances the efficiency of targeting more than 1,000 fold [52,53,104], 
expanding the applications of the mutagenesis system. From beginning to end, delitto 
perfetto yields the final strain in less than 2 weeks and has proven to be a very useful tool 
in molecular biology. Examples provided in this review illustrate many changes that can 
be created through removal of the CORE, such as point mutations, random mutations, 
deletions, insertions ranging from a few nucleotides to fragments several kilobases in 
size, and in vivo gene collage.  
 
3.3 MATERIALS 
3.3.1 Amplification of CORE 
1. Seven CORE plasmids are available (See Figure 3.1). 
2. DNA primers (Invitrogen, Carlsbad, CA; or Alpha DNA, Montreal, 
Quebec, Canada), desalted and non-purified: 50 pmol/µl. Store at -20°C. 
3. Ex Taq DNA polymerase, 10x buffer, 2.5 mM dNTPs (Clontech, 
Mountain View, CA). 
 
3.3.2 Gel Electrophoresis 




2. TBE running buffer (10x) (Fisher).  
3. Prestained molecular weight marker (New England Biolabs, Ipswich, 
MA). 
4. Loading dye (Fisher). 
 
3.3.3 PCR Product Concentration 
1. Ethanol (EtOH): 95% and 70% concentrations.  
2. Sodium acetate (NaOAc, Sigma, St. Louis, MO) 3 M (pH 5.2) stock 
solution, filter sterilized. Store at room temperature. (See Note 3.7.2). 
3.3.4 Transformation Reagents and Media 
1. YPD (per 1 l): 10 g yeast extract, 20 g soy peptone, 20 g dextrose 
(Difco/BD, Franklin Lakes, NJ). For solid media, add 20 g agar 
(Difco/BD). (See Note 3.7.3). 
2. YPLac liquid (per 1 l): 10 g yeast extract, 20 g soy peptone, 27 ml lactic 
acid (Difco/BD), pH adjusted to 5.5 with lactic acid (Fisher).  
3. Stock solution of 20% high-pure galactose (Sigma) is filter sterilized and 
stored at room temperature. 
4. Lithium Acetate (LiOAc, Sigma) stock of 1 M concentration filter 
sterilized and stored at room temperature. 
5. TE 10x stock solution: 100 mM Tris (Fisher) (pH 7.5), 10 mM 
ethylenediaminetetraacetic acid (EDTA; Sigma) (pH 7.5). Filter sterilize. 




6. Polyethylene glycol 4,000 (PEG 4,000; Sigma): 50% stock solution. Store 
at room temperature. (See Note 3.7.4). 
7. Working solutions: Solution 1 (0.1 M LiOAc, TE 1x, pH 7.5) and solution 
2 (0.1 M LiOAc, TE 1x, pH 7.5 in PEG 4000 50%).  
8. Solution of salmon sperm DNA (SSD, Roche, Basel, Switzerland), 100 
µg/ml. Store at -20°C. 
9. SC-Ura (Synthetic complete media lacking uracil) solid media (Fisher). 
10. Glass beads, approx. 5 mm diameter (Fisher).  
11. 5-Fluoroorotic Acid (5-FOA; per 1 l): Solution of 5-FOA is prepared by 
dissolving 1 g 5-FOA (US Biological, Swampscott, MA) in 300 ml of 
water prior to filter sterilization. 700 ml SD-complete (synthetic dextrose-
complete) agar media is autoclaved, then cooled to 55-60°C, and the 
filtered solution of 5-FOA is then mixed with media prior to pouring. 
12. G418 (per 1 l): YPD agar media is autoclaved, then cooled to 55-60°C, 
and G418 solution (200 µg/ml; US Biological) is then mixed with media 
prior to pouring. Stock solution is prepared in 50 mg/ml filter-sterilized 
aliquots and stored at 4°C.  
13. Hygromycin B (Hygro; per 1 l):  YPD agar media is autoclaved, then 
cooled to 55-60°C, and Hygro solution (300 µg/ml; Invitrogen) is then 
mixed with media prior to pouring.  
14. YPG (per 1 l): 10 g yeast extract, 20 g soy peptone, 30 ml glycerol 
(Difco/BD), 20 g agar.  




3.3.5 Genotypic Testing of Transformants 
1. Lyticase (Sigma) is dissolved at 2,000 U/ml and stored in 1 ml aliquots at 
-20°C.  
2. Taq DNA polymerase, 10x buffer, 10 mM dNTPs (Roche). 
 
3.3.6 Design of DNA Oligos for Removal of CORE and Generation of Mutations 
1. DNA oligos (Invitrogen or Alpha DNA): 50-100mers, desalted and non-
purified (50 pmol/µl). Store at -20°C. 
 
3.4 METHODS 
Despite the efficiency of recombination when a DSB is induced, induction of a DSB may 
not be required depending on the strain being mutagenized and the type of modification. 
The DSB system is preferred when multiple mutations are desired simultaneously; when 
the modification involves gross deletions, insertions, gene fusions, or other genomic 
rearrangements [104]; and when the strain is deficient in homologous recombination 
functions [52].  
 
Several combinations of two markers can be used for the delitto perfetto technique and 
are contained within the various CORE cassettes on plasmids (Figure 3.1). The two 
CORE markers are used for selection purposes and consist of the following: an antibiotic 




or Geneticin (G418)—and a COunterselectable marker, either the KlURA3 gene (a URA3 
homolog from Kluyveromyces lactis), which can be selected against using 5-FOA, or a 
marker coding for the human p53 mutant V122A, which is toxic to yeast when 
overexpressed and can be selected against using a galactose-containing media. In 
addition, the break system cassettes include the inducible GAL1 promoter and the I-SceI 
gene, used to induce the DSB at the 18-bp I-SceI break site.  
 
In the first step of delitto perfetto, the CORE is amplified through PCR to attach the tails 
of homology to the desired chromosomal locus (Fig 3.2A) and its PCR product is 
inserted into the cells by transformation (Figure 3.2B). The CORE cassette will then 
integrate at the desired genomic locus in approx. 1/10
6
 yeast cells via homologous 
recombination. Following transformation, the transformant colonies are isolated to 
observe for insertion of the CORE through phenotypic and genotypic testing. The second 
step of this technique is a transformation using oligos or other DNA to remove the entire 
CORE cassette and introduce the desired mutation(s) (Figure 3.2C). See Section 3.4.6 
for details on oligo design to remove the CORE. 
 
3.4.1 Amplification of CORE from Plasmid 
1. DNA primers will first be used to amplify the CORE from the chosen plasmid. 
These primers range from 70 to 100 bases in length with an overlap of at least 




cassette sequence (Table 3.1). Additionally, in the break-induced system, the 
18-bp recognition sequence for the I-SceI endonuclease is included on one of 
the two primers (Table 3.1). 
2. PCR conditions: Amplification of the CORE cassette from circular plasmid 
(about 50 ng) using 50 pmol/µl of each primer is performed with high yield in 
a final volume of 40 µl using Ex Taq DNA polymerase with a 2 min cycle at 
94°C; 32 cycles of 30 s at 94°C, 30 s at 57°C, and 4 min at 72°C (or 5 min at 
72°C for cassettes over 4 kb in size); a final extension time of 7 min at 72°C; 
and samples are held at 4°C. Ex Taq DNA polymerase consistently produces a 
higher yield of CORE cassette amplification than does Taq DNA polymerase. 
dNTPs (10 mM) are used for this reaction. An extension time of 1 min/kb is 
assumed for this reaction. 
3. Following PCR, the samples are ready for gel electrophoresis and PCR product 
concentration. 
 
3.4.2 Gel Electrophoresis  
1. We use a dilution of 0.5x TBE running buffer, which is obtained from 10x 
TBE by mixing 50 ml of 10x TBE buffer with 950 ml deionized water prior to 
use. 
2. A small aliquot (about 2 µl) of PCR product is run on a 0.8% agarose gel to 





3.4.3 PCR Product Concentration 
1. The product of six reactions of PCR are combined for precipitation with a 2.5x 
volume of 95% EtOH and 1/10 3 M NaOAc (pH 5.2) in a microcentrifuge 
tube. Centrifugation is carried out at maximum speed for 10 min. A small 
pellet should be visible on the bottom of the tube. 
2. The supernatant is discarded and the pellet is washed with 100 µl of 70% 
EtOH, paying attention not to detach the pellet. If the pellet is detached, it is 
necessary to spin again for 5 min and then discard the supernatant. Then, as 
much as possible of the EtOH is removed without detaching the pellet.  
3. The pellet is then dried in a speed vac for about 15 min and resuspended in 50 
µl of water. Five to 10 µl are used for each transformation. 
3.4.4 Step 1: Transformation to Insert the CORE 
The following transformation protocol is used to first insert the CORE PCR product into 
the strain of choice, and then to drive replacement of the CORE with DNA oligos or 
other segments of DNA. This transformation procedure has been modified from the 
lithium acetate protocol described by Wach, et al. [113]. During the transformation, the 
LiOAc acts to make the cell wall permeable. The presence of PEG 4000 is used to adhere 
the DNA to the cells such that the proximity will allow for entry into the cells. When 
transforming to insert the CORE PCR product, SSD is used to act as carrier DNA and 
serves as a buffer between the targeting DNA from the PCR and any DNA degradation 




CORE, the use of SSD is unnecessary as the oligos at the concentration of 1 nmole/20 µl 
act as carrier DNA themselves:  
1. Inoculate 5 ml of YPD liquid medium with chosen strain and shake at 30°C 
overnight (O/N). (See Note 3.7.5). 
2. Inoculate 50 ml of YPD liquid medium with 1.5 ml of the O/N culture in a 
250-ml glass flask and shake vigorously at 30°C for 3 h. 
3. Solution 1 and Solution 2 are prepared immediately prior to transformation.  
4. Transfer culture to a 50-ml conical tube and spin at 1,562 x g for 2 min. 
5. Remove the supernatant and wash cells with 50 ml of sterile water and spin as 
stated previously. 
6. Remove the supernatant and resuspend cells in 5 ml of solution 1 and spin as 
stated previously. 
7. Remove supernatant and resuspend cells in 250 µl of solution 1. This amount 
of cells is sufficient for approx. 7-8 transformations.  
8. Aliquot 50 µl of the cell suspension in microcentrifuge tubes and add 5-10 µl 
of concentrated CORE PCR product and 5 µl of SSD (heat-denatured SSD for 
5 min at 100°C prior to use and immediately kept on ice), then gently mix by 
tapping the tube. 
9. Add 300 µl of solution 2 for each transformation reaction. Mix briefly by 
vortexing. 
10. Incubate transformation reactions at 30°C for 30 min with shaking. 
11. Heat shock at 42°C for 15 min to drive the DNA into the cells. 




13. Remove supernatant and resuspend cells well in 100 µl of water. 
14. Plate all cells from each transformation tube on one SC-Ura plate using 
approx. 8-12 sterile glass beads and incubate at 30°C for 2-3 days. (See Note 
3.7.6). 
15. Using sterile velveteen, replica-plate from SC-Ura to G418- or Hygro-
containing media (depending on the CORE used) and incubate at 30°C O/N. 
16. Once transformants are observed (typically 5-30 colonies per plate), streak for 
single colony isolates on YPD solid media. Incubate at 30°C for 2 days. 
17. Make patches of the single colonies on new YPD solid media, along with the 
original strain, and incubate at 30°C O/N. 
18. Replica-plate the grown patches to YPD, SC-Ura, G418, Hygro, YPG to select 
against petite cells, and any other various selective media depending on the 
background of your strain, and incubate at 30°C O/N. 
19. Following observation of correct phenotype, the samples are ready for 
genotypic testing. 
 
3.4.5 Colony PCR of Transformants 
1. Resuspend cells (approx. 1 mm3) in 50 µl water containing 1 U of lyticase. 
Incubate at room temperature for 10 min, followed by incubation in a heat 
block at 100°C for 5 min. 
2. PCR conditions: Colony PCR of the transformant patches presenting the 




accomplished with 50 pmol of each primer, with an expected amplification 
region between 300 bp and 1.2 kb (See Figure 3.3). dNTPs (10 mM) are used 
for this reaction.  
3. PCR is performed in a final volume of 50 µl using Taq DNA polymerase 
(Roche) with a 2 min cycle at 95°C; 32 cycles of 30 s at 95°C, 30 s at 55°C, 
and 1 min at 72°C; a final extension time of 7 min at 72°C; and samples are 
held at 4°C. An extension time of 1 min/kb is assumed for this reaction. (See 
Note 3.7.7). 
4. Following PCR, samples are run on a 1% agarose gel (See Section 3.4.2) for 
observation of PCR product.  







Figure 3.3 Scheme of primer pairs used for colony PCR. Primers should be designed 
to allow for amplification of the target region in addition to being paired with primers 
internal to the CORE. The sizes of colony PCR products should range between 300 bp 
and 1.2 kb. Using this approach, verification of the CORE’s integration as well as its 
replacement can be made. See Table 3.1 for a list of primers and their sequences used to 
verify the integration of the various CORE cassettes. 
 
 
3.4.6 Design of DNA Oligos for Removal of CORE and Generation of Mutations 
Numerous mutations can be accomplished through the use of the delitto perfetto 
technique. These include substitutions, insertions, the generation of random mutations 
through the use of degenerate oligos, and deletions. Figure 3.4 illustrates the sequence of 
oligos (A-D) needed to produce all of these mutations at the genomic locus indicated in 
the figure. When substitutions or insertion mutations are desired, the location of the 
CORE insertion should be next to the region of modification. Conversely, the CORE 




desired. If a large deletion is desired, a CORE with the break system is inserted within the 
region to be removed [104].  
 
To remove the CORE and generate the mutation with DNA oligos, the following 
considerations should be made. The use of a single oligo is sufficient; however, a pair of 
complementary oligos increases the frequency of integration 5-10 fold [104]. 
Additionally, while shorter oligos (≈40 bp) can be used to effectively transform the 
strain, longer oligos approaching lengths of 80 bases are more favorable as they increase 
the efficiency of targeting as well as the window of mutagenesis [104]. The external 30-
40 bases of the oligo or oligo pair are used for efficient homologous recombination to 
introduce the desired mutation and allowing for loss of the CORE. It is of note that once 
the CORE cassette has been integrated in a specific chromosomal locus, many gene 
variants can be generated by transforming the cells with oligos designed to produce 
different alterations.  
 
3.4.7.1 Step 2: Transformation Using DNA Oligos in Non-Break System 
1. Inoculate 5 ml of YPD liquid medium with chosen strain and shake at 30°C 
(O/N). 
2. Inoculate 50 ml of YPD liquid medium with 1.5 ml of the O/N culture in a 250-
ml glass flask and shake vigorously at 30°C for 3 h. 





Figure 3.4 Examples of single oligo-driven mutations generated using the delitto 
perfetto technique. When a substitution or an insertion mutation is desired (A, B), the 
CORE should be placed next to the target region prior to replacement with a single or 
complementary oligo(s). In this example, the original sequence in the genome is provided 
as a reference at the top of the figure. (A) A substitution of a guanine, marked by an 
asterisk above the bolded G on the oligo, is made in place of the adenine residue on the 
top strand of the reference sequence (boxed). (B) An insertion mutation in the original 
sequence is created through the use of an oligo containing additional nucleotides (GCGG, 
marked in bold) which are inserted between the adenine and thymine indicated in the 
reference. When random mutations or small deletions (<5 kb) are desired (C, D) in a 
specific region, it is preferred to delete the region of interest along with the CORE 
insertion, as the successive targeting event with the oligos or other DNA will then 
eliminate the CORE and introduce the desired changes. The region of mutagenesis in the 
original sequence is bolded and indicated by the bracket. (C) For the generation of 
random mutations, the oligo sequence contains a stretch of 10 bolded Ns, which indicate 
that any of the four DNA bases can be used when the oligos are synthesized. The exact 
degree of this randomness is determined by the investigator. (D) The segment of the 
reference sequence indicated by the bracket can be removed through the use of oligos 
missing this fragment. In the example, the location of the deleted nucleotides is indicated 





4. Transfer culture to a 50-ml conical tube and spin at 1,562 x g for 2 min. 
5. Remove the supernatant and wash cells with 50 ml of sterile water and spin as 
stated previously. 
6. Remove the supernatant and resuspend cells in 5 ml of solution 1 and spin as 
stated previously. 
7. Remove the supernatant and resuspend cells in 250 µl of solution 1. This 
amount of cells is sufficient for approx. 7-8 transformations.  
8. Aliquot 50 µl of the cell suspension in microcentrifuge tubes and add 1 nmole 
of DNA oligos (heat-denatured for 2 min at 100°C, then immediately kept on 
ice prior to use). When using a single oligo, a 20 µl volume (at 50 pmol/µl) is 
used or when using a complementary DNA oligo pair, 10 µl of each is used. 
Gently mix the tube by tapping. 
9. Add 300 µl of solution 2 for each transformation reaction. Mix briefly by 
vortexing. 
10. Incubate transformation reactions at 30°C for 30 min with shaking. 
11. Heat shock at 42°C for 15 min to drive the DNA into the cells. 
12. Collect cells by centrifugation at 4,340 x g for 4 min. 
13. Remove the supernatant and resuspend cells well in 100 µl of water. 
14. Plate cells from each transformation tube on one YPD solid plate using approx. 
8-12 sterile glass beads and incubate at 30°C O/N.  
15. Using sterile velveteen, replica-plate from YPD to 5-FOA and incubate at 30°C 
for 2 days. If necessary, replica-plate again on 5-FOA media to allow for 
growth of Ura
-




16. Using sterile velveteen, replica-plate from 5-FOA to YPD and G418- or Hygro-
containing media (depending on the CORE used) and incubate at 30°C O/N. 
17. Mark G418-sensitive or Hygro-sensitive colonies on the YPD media and streak 
for single colonies on new YPD solid media. Incubate at 30°C for 2 days. 
18. Make patches of the single colonies on new YPD solid media, along with the 
original strain, and incubate at 30°C O/N. 
19. Replica-plate patches to YPD; SC-Ura; G418; Hygro; YPG, which selects 
against cells with defective mtDNA; and any other various selective media 
depending on the background of your strain, and incubate at 30°C O/N. 
20. Following observation of correct phenotype, the samples are ready for 
genotypic testing (See Section 3.4.5). 
21. PCR samples containing the mutagenized region are now ready for DNA 
purification and sequencing analysis. (See Note 3.7.9). 
 
3.4.7.2 Step 2: Transformation Using DNA Oligos in Break System 
1. Inoculate 50 ml of YPLac liquid medium with chosen strain in a 250-ml glass 
flask and shake at 30°C O/N. (See Note 3.7.10). 
2. Add 5 ml of galactose from a 20% solution into the O/N culture to obtain a 2% 
galactose solution and shake vigorously at 30°C for 3-6 h. (See Note 3.7.11). 
3. Solutions 1 and 2 are prepared immediately prior to transformation.  




5. Remove the supernatant and wash cells with 50 ml of sterile water and spin as 
stated previously. 
6. Remove the supernatant and resuspend cells in 5 ml of solution 1 and spin as 
stated previously. 
7. Remove the supernatant and resuspend cells in 250 µl of solution 1. This 
amount of cells is sufficient for approx. 7-8 transformations.  
8. Aliquot 50 µl of the cell suspension in microcentrifuge tubes and add 1 nmole 
of DNA oligos (heat-denatured for 2 min at 100°C, then immediately kept on 
ice prior to use). When using a single oligo, a 20 µl volume (at 50 pmol/µl) is 
used or when using a complementary DNA oligo pair, 10 µl of each is used. 
Gently mix the tube by tapping. 
9. Add 300 µl of solution 2 for each transformation reaction. Mix briefly by 
vortexing. 
10. Incubate transformation reactions at 30°C for 30 min with shaking. 
11. Heat shock at 42°C for 15 min to drive the DNA into the cells. 
12. Collect cells by centrifugation at 4,340 x g for 4 min. 
13. Remove the supernatant and resuspend cells well in 100 µl of water. 
14. Plate cells from each transformation tube on one YPD solid plate using approx. 
8-12 sterile glass beads and incubate at 30°C O/N. Dilutions may be necessary 
prior to plating due to the efficiency of oligo recombination following DSB 
induction. 
15. Using sterile velveteen, replica-plate from YPD to 5-FOA and incubate at 






 colonies clearly distinct from the background. (See Note 3.7.8). 
16.  Using sterile velveteen, replica-plate from 5-FOA to YPD and G418-or 
Hygro-containing media (depending on the CORE used) and incubate at 30°C 
O/N. 
17. Mark G418-sensitive or Hygro-sensitive colonies on the YPD media and streak 
for single colonies on new YPD solid media. Incubate at 30°C for 2 days. 
18. Make patches of the single colonies on new YPD solid media, along with the 
original strain, and incubate at 30°C O/N. 
19. Replica-plate patches to YPD; SC-Ura; G418; Hygro; YPG, which selects 
against cells with defective mtDNA; and any other various selective media 
depending on the background of your strain, and incubate at 30°C O/N. 
20. Following observation of correct phenotype, the samples are ready for 
genotypic testing. (See 3.4.5). 
21. PCR samples containing the mutagenized region are now ready for DNA 
purification and sequencing analysis. (See Note 3.7.9). 
 
3.5 EXAMPLES 
3.5.1 The  Delitto Perfetto Approach to Insert a Large DNA Fragment 
In Figure 3.5, the two-step process shown illustrates the insertion of a large segment of 
DNA, 10 kb in size. Generally, an insert of these proportions is obtained through 
amplification of the sequence through PCR, which, although possible, greatly increases 




the large DNA of interest is carried on a plasmid which is linearized prior to 
transformation. Linearization of the plasmid is required to generate free DNA ends and 
stimulate homologous recombination. The large segment of plasmid DNA is integrated 
into genomic DNA at a chosen location by in vivo recombination following co-
transformation of the linearized plasmid carrying the fragment and two pairs of 
complementary oligos. Each pair contains regions of homology to either side of the target 
site in addition to homology with the 10-kb fragment, thereby directly driving it into its 
desired locus. This way, sequencing analysis is not required following integration of the 
large fragment. 
 
3.5.2 The Delitto Perfetto Approach to Insert Multiple Sequences for Gene Collage 
It is also possible to insert two or more sequences or genes next to each other 
simultaneously using delitto perfetto, as seen in Figure 3.6.  To accomplish this, the 
genes or segments of interest are amplified in such a way that the primers of each PCR 
fragment have tails of homology to the sequence of the contiguous segment and the most 
external primers contain homology to the target site. Through co-transformation with 
these multiple PCR products, the individual pieces recombine in vivo as a form of gene 








Figure 3.5 Insertion of a large segment of DNA from a plasmid. In this example, the 
break system is used to drive the integration of a 10-kb fragment from a plasmid into the 
target region. (a) First, the GSHU CORE cassette and the 18-bp I-SceI break site are 
inserted into the target region. (b) Next, the plasmid carrying the sequence of interest to 
be integrated within the genome is linearized by restriction digestion outside of the 
fragment to be inserted. Complementary pairs of oligos have regions of homology to both 
the upstream and downstream portions of the sequence of interest to be integrated, as 
well as to either side of the target region. The linearized plasmid and oligos are co-
transformed into yeast cells following DSB induction at the I-SceI site. By homologous 
recombination, the large sequence of interest is integrated into the genomic DNA at the 
specific site without the need for PCR amplification, which otherwise increases the 







Figure 3.6 Mechanism of in vivo gene collage by the delitto perfetto approach. (a) In 
step one, the GSKU CORE cassette is amplified through PCR, with the 18-bp I-SceI 
break site included within the sequence of one primer. This product is inserted into the 
target locus. (b) Prior to replacement of the cassette, a preparation step to generate PCR 
fragments is performed. For this example, a gene of interest will be attached to a chosen 
promoter and terminator sequences and all components will be inserted at a chosen locus. 
(c) In step two, the multiple PCR fragments assemble together in vivo by recombination 
to form a large fragment, which then replaces the GSKU cassette as it integrates into its  





Note 3.7.1  
This review focuses on the generation of engineered haploid strains of yeast. For the use 
of delitto perfetto in diploid cells, refer to [104] for a detailed explanation of 
modifications to the protocol. 
 
Note 3.7.2  
For media preparation, deionized water is used. All other uses of the term “water” in this 
chapter, however, refer to deionized water that was sterilized by filtration or autoclaving. 
 
Note 3.7.3 
Unless otherwise noted, all solid media is to be stored at 4°C. Exceptions include YPD 
liquid and agar, which we store at room temperature. 
 
Note 3.7.4 
PEG 4000 solution will be extremely viscous, so filter sterilizing can take up to one hour 
depending on the volume. Autoclaving is an alternative means of sterilization.   
 
Note 3.7.5 
Using 50-ml conical tubes for O/N growth is preferred to using 15-ml tubes, as the larger 
size allows for greater dispersion of the nutrients in the broth to each of the cells. 
Additionally, S. cerevisiae is an aerobic species, so lids should not be capped tightly but 





When inserting CORE, if growth on SC-Ura media is not observed after 3 days (See Note 
3.7.8 below), the transformation can be performed by plating onto YPD and incubating at 
30°C O/N followed by replica-plating to G418- or Hygro-containing media, depending 
on the CORE used, and incubating at 30°C for 2-3 days until large colonies appear. This 
would then be followed by replica-plating to SC-Ura and incubating at 30°C O/N. 
 
Note 3.7.7 
As little as 5 µl of the cell resuspension solution can be used per reaction; however, this 
is not optimal when sequencing is necessary and a volume of 10 µl is suggested here. 
 
Note 3.7.8 
The following is specific to using CORE-UK, CORE-UH, GSKU, and GSHU, as this 
does not apply to the other cassettes. When KlURA3 is inserted in the same orientation as 
the targeted gene, interference from that gene’s promoter during transcription may lead to 
delayed growth on SC-Ura in the first step of delitto perfetto (See Note 3.7.6 above) and 
may increase the number of background cells on 5-FOA in the second step. Depending 
on insertion orientation of the CORE, a second round of replica-plating to 5-FOA may be 
needed. Therefore, it is optimal to insert the cassette in such a way that KlURA3 is 
oriented opposite to the gene being targeted.  
 
Note 3.7.9 




sequence, sequencing analysis is not required. The resulting antibiotic resistance and 
Ura
+
 phenotype of the strain in addition to the results of the colony PCR are sufficient to 
provide evidence for successful incorporation of the CORE into the targeted site. 
Sequencing is, however, necessary to verify the correct insertion of the desired 
mutation(s). Since the oligos used are non-purified, the expected additional mutations are 
in the range of 10-20%. Therefore, it is always better to obtain 3-5 clones for sequencing. 
 
Note 3.7.10 
YPLac is used to provide a neutral carbon source for the cells prior to addition of 
galactose. However, cells grow much slower in this medium. It is, therefore, optimal to 
inoculate cells into YPLac at least 18-20 h prior to the transformation. 
 
Note 3.7.11 
Addition of galactose activates the inducible GAL1 promoter which regulates the I-SceI 
gene. Experience has shown that longer induction (5-6 h) produces greater efficiency. 
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DSB-DRIVEN GENETIC MODIFICATION IN HUMAN CELLS USING DNA 
OLIGOS 
 
The procedure and results detailed in Chapter 5 are modified from work published in 
Mutation Research [128]: 
Shen, Y., Nandi, P., Taylor, M.B., Stuckey, S., Bhadsavle, H.P., Weiss, B., and Storici, 




We developed two systems for testing recombination in human cells using synthetic 
DNA oligos to repair an endonuclease-induced break. In one system recombination is 
tested at a target green fluorescent protein (GFP) locus on a plasmid, and in the other 
system the target locus has been stably-integrated into the genome of human embryonic 
kidney (HEK-293) cells. The break site, positioned within the coding sequence of a 
reporter gene, can be targeted for cleavage following expression of the nuclease. 
Following generation of the break, recombination using a single-stranded oligo can fix 




we demonstrate the use of these systems to efficiently repair a lesion at a plasmid and a 
chromosomal locus in human cells.  
 
4.2 INTRODUCTION 
Many diseases exist due to underlying genetic abnormalities. These can include 
multifactorial diseases, such as diabetes and certain types of cancer, as well as 
monogenetic disorders, such as cystic fibrosis and retinitis pigmentosa, otherwise known 
as tunnel vision [7-10,129,130]. While certain types of therapy could be used to mediate 
symptoms of some genetic diseases, a more permanent strategy to correct the defect 
would provide the most optimal treatment strategy. With this idea in mind, gene targeting 
was developed as a strategy to intentionally and precisely target a chromosomal locus for 
replacement with a similar sequence. Thus, through replacement with an allele carrying 
the correct genetic sequence a disease could be “cured” at the chromosomal level [36]. 
Gene targeting relies on HR, which exists naturally to allow for exchange between 
similar genetic sequences through such processes as meiotic recombination or to repair 
chromosomal breaks [36].  However, HR is highly inefficient in many organisms 
including humans [60]. In order to promote recombination, scientists determined that a 
targeted DNA DSB could efficiently be used as it is a naturally occurring substrate for 
the HR machinery [131,132]. Generation of a DSB has been shown to stimulate 
recombination in many organisms, including human cells, more than 1,000-fold 
[49,51,60], thus helping to establish gene targeting as an effective strategy for potentially 




While a DSB can efficiently trigger the HR machinery, a great deal of variability in 
results has been noted between different labs due to numerous factors. For example, 
varying levels of recombination events have been observed based on the target locus, 
repair substrate, DSB-producing nuclease used, and the specificity of the enzyme to its 
recognition sequence [59-61,133]. For our studies, we aimed to develop a system which 
would allow us to directly compare different nucleases for their recombination potential 
at the same target plasmid or chromosomal locus in human cells. Previously, synthetic 
DNA oligos were shown to efficiently repair a targeted DSB in yeast cells both at and 
distant from the site of a DSB [53,103] and at the site of a break in human cells 
[98,134,135]. Additionally, a plasmid construct and subsequent stable, monoclonal cell 
line were developed which could be used to observe recombination at a disrupted GFP 
locus [60]. By merging these concepts, we were able to develop an assay for detecting 
recombination after generating a site-directed break within the GFP gene followed by 
repair using synthetic DNA oligos.  
 
We first focused on generating a DSB using the I-SceI protein, previously shown to 
stimulate recombination in many organisms, including human cells, up to 1,000-fold or 
more [51,53,54,60,133]. In the plasmid assay, a plasmid containing the 18-bp I-SceI 
recognition site within GFP was transfected into human cells along with a plasmid 
expressing I-SceI and DNA oligos complementary to either side of the disruption (Figure 
4.1 left side). Following generation of the DSB, if the sequence from the oligos was used 




chromosomal GFP locus could be targeted following expression of I-SceI from the 
plasmid and co-transfection with the oligo(s) (Figure 4.1 right side). Our results 
demonstrate that an I-SceI DSB can efficiently be repaired at the GFP locus on a plasmid 




Figure 4.1 Scheme of repair at the target locus in human cells.  In the system used, a 
disrupted GFP marker can be repaired after generation of a DSB within the marker 
followed by repair with oligos homologous to either side of the region flanking the 
disruption. For both the plasmid (left) and chromosomal (right) target locus, the 18-bp 
recognition sequence for I-SceI is located within the disrupted gene. After I-SceI is 
expressed, it generates a break which can be repaired using oligos that can knock out the 
disruption and restore the sequence of the gene. Cells are non-fluorescent prior to repair 






4.3 MATERIALS AND METHODS 
4.2.1 Human cell lines and culture 
HEK-293 cells were grown in Dulbecco’s modified Eagle’s medium (DMEM), 
supplemented with 10% heat-inactivated fetal bovine serum (FBS) and 1x 
penicillin/streptomycin, at 37ºC in a 5% CO2 incubator. 658D cells were generated 
previously through random integration of a disrupted green fluorescent protein (GFP) 
marker into the genome [60].Within the 35-bp disruption at the GFP locus are two stop 
codons and the 18-bp recognition sequence for the I-SceI endonuclease (Figure 4.1). 
 
4.2.2 Plasmids 
Plasmid pA658 contains a disrupted GFP marker under the CMV/CBA hybrid promoter 
and was stably integrated into HEK-293 cells to generate the 658D cell line [60]. The 35-
bp disruption in the middle of GFP contains two stop codons and the 18-bp cognate 
recognition sequence for the I-SceI endonuclease (Figure 4.1). Plasmid p67 contains the 
I-SceI endonuclease gene under the CMV/CBA hybrid promoter [60]. 
 
4.2.3 Oligos 
Synthetic DNA oligos were designed as 80mers. GFP80.F (F, 5’ –GCGCACCATCTTC 
TTCAAGGACGACGGCAACTACAAGACGCGCGCCGAGGTGAAGTTCGAGGGC 
GACACCCTGGTGAACC) contains the same sequence as the coding strand of GFP and 
has 40-bases of homology to the region 5’ of the break site in GFP and 39-bases of 




nucleotide which creates a silent substitution in GFP, generating the BssHII restriction 
site.  GFP80.R (R, 5’ – GGTTCACCAGGGTGTCGCCCTCGAACTTCACCTCGGCGC 
GCGTCTTGTAGTTGCCGTCGTCCTTGAAGAAGATGGTGCGC) is the reverse 
complement sequence of GFP80.F. 
 
4.2.4 Transfection 
Cells were seeded with approx. 50,000 cells per well in a 24-well plate 24 h prior to 
transfection. In transfection experiments, plasmid DNA was used in the amount of 0.5 µg 
of DNA per well while oligo DNA was 1.5 µg. Prior to transfection, DNA was diluted in 
DMEM without supplements and vortexed with polyethylenimine (PEI) transfection 
reagent at 5 µg of PEI per well. Mixtures were incubated at room temperature for 30 min 
prior to being added drop-wise into the well. 
 
4.2.5 Detection and quantification of recombinants 
Cells were observed beginning on day two following transfection using a fluorescent 
microscope. Frequencies of GFP
+
 cells were obtained by flow cytometric analysis using 
the BD LSR II flow cytometer (BD Biosciences, Sparks, MD). 100,000 cells were 
counted for each sample. 
 
4.2.6 Statistical analysis 
All graphs were created using the GraphPad Prism 5 software (GraphPad Software, Inc.). 
Data are plotted as median values with the range displayed as bars. Statistical 





4.3.1 DNA oligos can efficiently repair a DSB in human cells  
Following transfection to repair the targeted plasmid GFP locus, for all negative controls 
≤1 green fluorescent cell per 100,000 cells read was detected. However, recombination 
using the complementary pair was less efficient than with either of the single oligos 
(p≈0.0294) (Figure 4.2). Thus, for subsequent experiments we used only combinations 
including either of the oligos as a repair template, but not both simultaneously. 
 
Compared to when only the repair template and either oligo were provided, generation of 
the DSB at the target plasmid locus followed by repair with either F or R led to a 
significant increase in GFP
+
 recombinants (p≈0.0066) (Figure 4.2 and Figure 4.3). 








Figure 4.2 DSB-driven recombination at a target plasmid locus.  Levels of GFP
+ 
cells 
following expression of I-SceI oligos to repair the break in GFP. Cells only contains cells 
transfected with no additional DNA. The plasmid used is shown in the scheme depicted 
in Figure 4.1. F = oligo complementary to the anti-sense strand of the gene. R = oligo 
complementary to the sense strand. Pair = F + R. Plasmid = plasmid containing disrupted 
GFP marker. DSB = plasmid expressing I-SceI. All data are presented as the median with 
range.  
 





Figure 4.3 A DSB stimulates recombination on the plasmid.  Levels of GFP
+ 
cells 
following expression of I-SceI and transfection with oligos to repair the break in GFP. 
Cells only contains cells transfected with no additional DNA. F = oligo complementary 
to the anti-sense strand of the gene. R = oligo complementary to the sense strand. Plasmid 
= plasmid containing disrupted GFP marker. DSB = plasmid expressing I-SceI. All data 
are presented as the median with range.  




Similar to the results at the plasmid GFP locus, an increase in the frequency of GFP
+
 
cells was observed using both the single F and R oligo at the chromosomal GFP locus 
(Figure 4.4). For all negative controls ≤1 green fluorescent cell per 100,000 cells read 
was detected. Compared to when no DSB was induced, generation of a DSB at the target 
chromosomal locus followed by repair with either F or R led to a significant increase in 
GFP
+
 recombinants (p≈0.0018 and p≈0.0002, respectively). Additionally, a strand bias in 
favor of the F oligo was observed (p<0.0001). 
 
 
Figure 4.4 A DSB stimulates recombination on the chromosome.  Levels of GFP
+ 
cells following expression of I-SceI and transfection with oligos to repair the break in 
GFP. Cells only contains cells transfected with no additional DNA. F = oligo 
complementary to the anti-sense strand of the gene. R = oligo complementary to the 
sense strand. Plasmid = plasmid containing disrupted GFP marker. DSB = plasmid 
expressing I-SceI. All data are presented as the median with range.  





We demonstrated here that the system we use to stimulate recombination at the site of a 
DSB in human cells using synthetic DNA oligos works both on plasmid and on 
chromosomal DNA. For samples in which the repair template and target locus were 
provided and no DSB was generated, ≤1 fluorescent cell per 100,000 cells was detected 
(Figures 4.3 and 4.4). However, when the plasmid expressing I-SceI was also transfected 
into the cells a significant increase in GFP
+
 cells was observed. Each of the single oligos 
was able to repair the break at the GFP locus, both on the plasmid (Figure 4.3) and on 
the chromosome (Figure 4.4), as evidenced by an increase in GFP
+
 cells following 
generation of the DSB and co-transfection with either of the repair templates. The length 
of homology of these oligos (40 bases upstream of the disruption and 39 bases 
downstream with an additional base creating a silent mismatch) was sufficient to restore 
the sequence of the marker. Additionally, a strand bias in favor of one oligo (F, which 
represents the sense strand of the gene) was observed at the locus in both systems. 
However, the wider implications of this cannot easily be attributed as previous findings 
have observed a bias in favor of either the sense or anti-sense strand oligo which varies 
depending on the target locus [98,134,135]. 
 
Differently from findings in yeast that the complementary pair of oligos is generally most 
favorable for repair of an I-SceI DSB at a target locus [53], we observed that the 
complementary pair was least efficient compared to either of the single oligos in human 




found shorter single-stranded DNA oligos (~35-80 nt) were more favorable templates for 
repair of various episomal or chromosomal loci than a similar double-stranded construct 
[98,135]. While the exact reason for this is unclear, it was proposed that perhaps the 
double-stranded oligos first must unfold prior to hybridization with a target locus [98]. 
Additionally, it is possible that a blunt-ended double-strand sequence, such as that used 
for our assay, is recognized as DNA damage, triggering a checkpoint response and 
degradation.   
 
Ultimately, our findings illustrate the capabilities of single-stranded synthetic DNA 
oligos to repair a target locus in human cells. These oligos are of sufficient length to 
restore the sequence of the gene, and the transfection method we use (transfection with 
PEI) is able to allow the cells to uptake the DNA. Finally, the system we use allows for 
rapid and easy detection of recombination events as fluorescent cells can be readily 








GENETIC MODIFICATION STIMULATED BY THE INDUCTION OF A SITE-
SPECIFIC BREAK DISTANT FROM THE LOCUS OF CORRECTION IN 
HAPLOID AND DIPLOID YEAST SACCHAROMYCES CEREVISIAE 
 
The procedures detailed in Chapter 5 are modified from a publication of the same name 
in the Methods in Molecular Biology book series, Gene Correction edition [136]: 
Stuckey, S. and Storici, F. (2013). School of Biology, Georgia Institute of Technology, 
Atlanta, GA. Meth Mol Biol 
 
5.1 ABSTRACT 
Generation of a site-specific break at a genomic locus to stimulate homologous 
recombination (HR) is used in many organisms to efficiently target genes for various 
types of genetic modification. Additionally, a site-specific chromosomal break can be 
used to trigger HR at genomic regions distant from the break, thereby largely expanding 
the region available for introducing desired mutations. In contrast to the former approach, 
the latter presents an alternative way in which genes can be efficiently modified also 
when it is not possible or desirable to introduce a break in the vicinity of the targeting 
locus. This type of in vivo site-directed mutagenesis distant from a break can be 




generation of a double-strand break (DSB) in yeast chromosomal DNA activates HR at 
long regions upstream and downstream from the break site. Here we provide a protocol 
for efficiently altering a yeast chromosomal locus following the induction of a DSB 
several kilobase pairs distant from the site of gene correction. The techniques described 
can be used in both diploid and haploid yeast strains, and we provide examples of the 




Gene targeting is a genetic technique that uses homologous recombination (HR) to 
modify an endogenous DNA sequence. Using this technique, various genetic 
manipulations are possible, including gene knock-out for functional analysis, gene knock-
in to provide selectable markers or for heterologous gene insertion, generation of specific 
point mutations to alter the function of a desired gene or regulatory sequence, 
introduction of particular polymorphisms, or correction of genetic defects [137]. Gene 
targeting has been used extensively in many cellular systems, from bacteria to human 
cells [27,29,32,34,49,60,63,138]. Despite the wide applications of the gene targeting 
technique, the generally low efficiency of HR in nearly all organisms has always been a 
challenge for researchers [21,139,140]. One of the most effective ways to increase gene 
targeting in chromosomal DNA is via the induction of a site-specific DNA double-strand 
break (DSB) near the genomic site to be changed [49,51,131]. Indeed, a DSB can 
stimulate HR up to several thousand-fold over natural levels [60,141,142]. What 




in the genomic DNA. It is the generation of regions of single-stranded DNA, following 
processing of the break ends and strand resection in a 5’ to 3’ direction in preparation for 
break repair, that makes the DNA at the broken locus highly recombinogenic [52]. If a 
DSB occurs in DNA but formation of single-stranded DNA is impeded, gene targeting by 
HR is not stimulated [52]. During the process of DSB repair, the gap of single-stranded 
DNA that is generated can be filled in using homologous templates [52,143]. Therefore, 
it is possible to increase the efficiency of gene correction in chromosomal DNA also 
using targeting molecules that do not physically repair the break but that have 
complementarity with the single-stranded regions to either side of the break [52]. This 
approach of gene modification at sites distant from the DSB works well in the yeast 
Saccharomyces cerevisiae, in which long regions of single-stranded DNA can be 
generated following induction of a DSB [52,144]. Major advantages of this strategy are i) 
a large window for mutagenesis expanded up to 20 kb from each side of the DSB, ii) the 
possibility to perform gene correction in essential genes, and iii) the applicability of the 
approach to diploid in addition to haploid cells [51-53,59,104,145]. 
 
When applying gene targeting distant from sites of induced breaks in cellular systems 
different from the yeast S. cerevisiae, it should be taken into consideration that the 
efficiency of genetic modification at a locus distant from a break is limited by the length 
of the single-stranded DNA regions surrounding the DSB, which varies between 
organisms. Following generation of a DSB, 5’ to 3’ resection on both sides of the break 




of kilobases [144], providing a large window of opportunity for modification at distant 
loci. Studies in mammalian cells, though, indicate the lengths of resection are much 
shorter, less than 2 kb [146]. Thus, while generation of a distant DSB can improve gene 
targeting applications by enlarging the window of opportunity for creating modifications, 
factors such as resection lengths can also limit this window. 
Though highly efficient in yeast cells, gene targeting at regions distant from the site of 
DNA breakage could potentially be adapted to other cellular systems. The opportunity to 
exploit a wider window of mutagenesis, even a few hundred nucleotides longer, from the 
site of breakage may already provide a significant advantage. Generation of a DSB at a 
genomic locus in which the desired genetic modification will be made may not always be 
feasible, and in some situations it is favorable to generate a break distant from the 
position to be modified. For example, designed nucleases, such as zinc-finger nucleases 
(ZFNs) or transcription activator-like effector nucleases (TALENs), are created to 
recognize and cleave specific genomic loci [58,61,64,147]. In order to design the most 
effective designer nucleases, however, targeted genomic regions must contain highly-
specific nucleotide sequences recognizable by each of the nucleases and appropriately 
spaced relative to each other such that dimerization of the nucleases can occur. Thus, the 
sequence constraints of these enzymes may require their recognition sites to be located at 
some distance from the genomic locus to be modified. Additionally, recent advancements 
with systems naturally involved in the adaptive immune systems of bacteria and archaea 
have demonstrated the capability of RNA-driven targeted gene correction [69,70]. 
Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR associated 




in the genome for targeted generation of a site-directed break [69,70]; however, as with 
ZFNs and TALENs, the genetic locus to be targeted for gene correction may exist at 
some chromosomal position distant from the most favorable sequence for recognition by 
these CRISPR elements. If the gene targeting sites are distant from the most optimal 
recognition sequences for a break to be generated but still in regions that can become 
single-stranded after DSB induction, the gene correction efficiency will be much higher 
than without DSB induction.  
 
Here we provide a protocol for modification of a locus distant from a DSB in the yeast S. 
cerevisiae using synthetic DNA oligos as gene-correction templates. We explain in a 
step-wise fashion procedures in which a cassette containing an inducible I-SceI 
endonuclease gene and its 18-bp recognition site can be integrated into the genome of 
haploid or diploid yeast strains and used to stimulate genetic modification of regions 
several kb away from the initial chromosomal break point. 
 
5.3 MATERIALS 
5.3.1 Amplification of CORE-I-SceI 
1. Two CORE-I-SceI plasmids (pGSKU, pGSHU) are available (See [120] 
for further plasmid information). 




3. Ex Taq DNA polymerase, 10x buffer, 2.5 mM dNTPs (Clontech 
Laboratories, Inc., Mountain View, CA, USA). 
 
5.3.2 Gel Electrophoresis 
1. Agarose. 
2. 10x Tris/Borate/EDTA (TBE) running buffer.  
3. Prestained molecular weight marker. 
4. Loading dye. 
 
5.3.3 PCR Product Concentration 
1. 95% Ethanol (EtOH). 
2. 70% EtOH. 
3. 3 M Sodium acetate (NaOAc; pH 5.2) solution in water: Filter-sterilized. 
Stored at room temperature (See Note 5.6.1). 
 
5.3.4 Transformation Reagents and Media 
1. YPD (per 1 l): 10 g yeast extract, 20 g bacto peptone, 20 g dextrose. 
Autoclaved for 45 min at 121ºC. 20 g agar is added for solid medium prior 
to autoclaving (See Notes 5.6.2 & 5.6.3). 
2. YPLac liquid (per 1 l): 12 g sodium hydroxide (NaOH), 10 g yeast extract, 
20 g bacto peptone, 27 ml lactic acid, pH adjusted to 5.5 with lactic acid. 




3. 20% Highly pure galactose stock solution in water: Filter-sterilized. Stored 
at room temperature. 
4. 1 M Lithium acetate (LiOAc) stock solution in water: Filter-sterilized. 
Stored at room temperature. 
5. 10x TE stock solution: 100 mM Tris (pH 7.5), 10 mM 
ethylenediaminetetraacetic acid (EDTA) (pH 7.5) in water. Filter-
sterilized. Stored at room temperature. 
6. 50% Polyethylene glycol 4000 (PEG 4000) stock solution in water: Stored 
at room temperature (See Note 4). 
7. Working solutions: Solution 1 (0.1 M LiOAc, TE 1x, pH 7.5 in water) and 
solution 2 (0.1 M LiOAc, TE 1x, pH 7.5 in 50% PEG 4000). 
8. 100 µg/ml Salmon sperm DNA (SSD) in water: Stored at -20°C. 
9. Synthetic complete medium lacking uracil (SC-Ura) solid medium. 
10. Synthetic dextrose complete (SD Complete) solid medium. 
11. Glass beads approximately 5 mm diameter.  
12. 5-Fluoroorotic acid (5-FOA; per 1 l): Solution of 5-FOA is prepared by 
dissolving 1 g 5-FOA in 300 ml of water prior to filtration. 700 ml SD 
Complete agar medium is autoclaved for 45 min at 121ºC, then cooled to 
55-60°C, and the filter-sterilized solution of 5-FOA is then mixed well 
with medium prior to pouring. 
13. G418 (per 1 l): YPD agar medium is autoclaved for 45 min at 121ºC ,then 




prior to pouring. Stock solution is prepared in water in 50 mg/ml filter-
sterilized aliquots and stored at 4°C.  
14. Hygromycin B (hygro; per 1 l): YPD agar medium is autoclaved for 45 
min at 121ºC, then cooled to 55-60°C, and hygromycin B solution is then 
mixed well with medium prior to pouring.  
15. YPG (per 1 l): 10 g yeast extract, 20 g bacto peptone, 30 ml glycerol, 20 g 
agar. Autoclaved for 45 min at 121ºC. 
16. Sterile velveteens. 
 
5.3.5 Genotypic Testing of Transformants 
1. 2000 U/ml lyticase in water: Stored in 1 ml aliquots at -20°C.  
2. Taq DNA polymerase, 10x buffer, 10 mM dNTPs. 
 
5.3.6 Design of DNA Oligos for Modification of Distant Loci and Repair of DSB 
       1. 50 µM DNA oligo stock solution: 40-100mers, desalted and non-purified.  
           Store at -20°C. 
 
5.4 METHODS 
Here we describe a method for generating an I-SceI site-specific DSB in yeast 
chromosomal DNA which will be used to stimulate gene targeting at a region distant 
from the DSB site both in haploid and diploid yeast cells. The initial steps are common 




a CORE-I-SceI cassette. The cassettes contain COunterselectable and REporter markers 
for selection, hence the name. Two of these plasmids (pGSKU and pGSHU) contain the 
I-SceI site-specific endonuclease gene, regulated by a galactose-inducible promoter, 
GAL1.The cassettes from these plasmids, hereafter referred to as the CORE-I-SceI 
cassettes, will be amplified through polymerase chain reaction (PCR) and then 
transformed into the strain of interest. Additionally, during PCR the 18-bp cognate 
recognition sequence for I-SceI is introduced at one end of the cassette by one of the 
primers. This site will later be used for the DSB-driven repair assay as the expressed I-
SceI protein will recognize it to generate the site-directed break. We further provide 
examples of repair assays in both haploid and diploid yeast strains. Additional material 
on the available CORE-I-SceI cassettes has been previously published elsewhere 
[52,102,120]. 
 
5.4.1 Amplification of CORE-I-SceI from Plasmid 
1. DNA primers will first be used to amplify the CORE-I-SceI cassettes 
(GSKU or GSHU) from the chosen plasmid. These primers range from 70 
to 88 bases in length with an overlap of at least 50 bp with the genomic 
targeting region and an overlap of 20 bp to the CORE-I-SceI cassette 
sequence. Additionally, the 18-bp recognition sequence for the I-SceI 
endonuclease is included on one of the two primers (See [120] for further 




2. PCR conditions: Amplification of the CORE-I-SceI cassette from circular 
plasmid (about 50 ng) using 50 pmol of each primer is performed with 
high yield in a final volume of 40 µl using Ex Taq DNA polymerase with 
a 2 min cycle at 94°C; 32 cycles of 30 s at 94°C, 30 s at 57°C, and 5 min 
at 72°C; a final extension time of 7 min at 72°C; and samples are held at 
4°C. Stock concentrations of 10 mM dNTPs are used for this reaction. An 
extension time of 1 min/kb is assumed for this reaction (See Note 5.6.5). 
3. Following PCR, the samples are ready for gel electrophoresis and PCR 
product concentration. 
 
5.4.2 Gel Electrophoresis  
1. We use a dilution of 0.5x TBE running buffer, which is obtained from 10x 
TBE by mixing 50 ml of 10x TBE buffer with 950 ml deionized water 
prior to use. 
2. A small aliquot (about 2 µl) of PCR product is run on a 0.8% agarose gel 
to observe the anticipated band. 
5.4.3 PCR Product Concentration 
1. The product of six reactions of PCR are combined for precipitation with a 
2.5x volume of 95% EtOH and 0.1x volume of 3 M NaOAc (pH 5.2) in a 
microcentrifuge tube. Centrifugation is carried out at maximum speed for 




2. The supernatant is discarded, and the pellet is washed with 100 µl of 70% 
EtOH, being careful not to detach the pellet. If the pellet is detached, it is 
necessary to spin again for 5 min and then discard the supernatant. Then, 
as much as possible of the EtOH is removed without detaching the pellet.  
3. The pellet is then spun until dry in a speed vacuum device and then 
resuspended in 50 µl of water. Five to 10 µl are used for each 
transformation. 
 
5.4.4 Transformation to Insert the CORE-I-SceI Cassette 
The following protocol is used to insert the CORE-I-SceI PCR product into the chosen 
strain. This procedure applies to both haploid and diploid strains. As the CORE-I-SceI 
cassettes, GSKU and GSHU, each contain multiple markers (the URA3 gene from 
Kluveromyces lactis and resistance genes to the antibiotics G418 or Hygromycin B, 
respectively), the strain should have a non-functional URA3 gene and should be G418- 
and hygromycin B-sensitive to ensure proper integration at the desired locus. This 
procedure has been modified from the lithium acetate protocol described by Wach et al. 
[113]. A more detailed explanation of the involved steps has been previously published 
by our group in the Methods in Molecular Biology series [120]. 
1. Inoculate 5 ml of YPD liquid medium with chosen strain and shake at 
30°C overnight (O/N) (See Note 5.6.6). 
2. When cells are in logarithmic growth (approximately 16 h later), inoculate 




 glass flask and shake vigorously at 30°C for 3 to 4 h. 
3. Solutions 1 and 2 are prepared immediately prior to transformation.  
4. Transfer culture to a 50-ml conical tube and spin at 1562 x g for 2 min. 
5. Remove the supernatant and wash cells with 50 ml of sterile water and 
spin as stated previously. 
6. Remove the supernatant and resuspend cells in 5 ml of solution 1 and spin 
as stated previously. 
7. Remove supernatant and resuspend cells in 250 µl of solution 1. This 
amount of cells is sufficient for up to approximately 10 transformations.  
8. Aliquot 50 µl of the cell suspension in microcentrifuge tubes and add 5-10 
µl of concentrated CORE-I-SceI PCR product and 5 µl of SSD (heat-
denatured for 5 min at 100°C prior to use and immediately kept on ice). 
9. Add 300 µl of solution 2 to each transformation tube. Mix briefly by 
vortexing. 
10. Incubate transformation tubes at 30°C for 30 min with shaking. 
11. Heat shock at 42°C for 15 min. 
12. Collect cells by centrifugation at 2236 x g for 4 min. 
13. Remove the supernatant and resuspend cells well in 100 µl of sterile 
water. 
14. Plate all cells from each transformation tube on one SC-Ura plate using 
approximately 15 sterile glass beads and incubate at 30°C for 2-3 days 




15. Using a sterile velveteen, replica-plate from SC-Ura to G418- or hygro-
containing medium (depending on the CORE used) and incubate at 30°C 
O/N. 
16. Once transformants are observed (typically 5 to 30 colonies per plate), 
streak for single colony isolates on YPD solid medium. Incubate at 30°C 
for 2 to 3 days. 
17. Make patches of the single colonies onto new YPD solid medium, along 
with the original strain for phenotypic comparison, and incubate at 30°C 
O/N. 
18. Replica-plate the grown patches to YPD; SC-Ura; G418; hygro; yeast 
extract-peptone-glycerol (YPG) solid medium , which selects against cells 
with defective mitochondrial DNA (mtDNA); and any other various 
selective media depending on the background of your strain, and incubate 
at 30°C O/N. 
19. Following observation of correct phenotype, the samples are ready for 
genotypic testing. 
 
5.4.5 Colony PCR of Transformants 
1. Resuspend cells (approximately 1 mm3) in 50 μl water containing 1 U of 
lyticase. Incubate at room temperature for 10 min, then heat at 100°C for 5 




2. PCR conditions: Colony PCR of the transformant patches showing the 
expected phenotypes using 10 μl of the cell resuspension mixture is 
carried out with 50 pmol of each primer and with an expected amplified 
product size ranging between 300 bp and 1 kb. Stock concentrations of 10 
mM dNTPs are used for this reaction. PCR is performed in a final volume 
of 50 µl using Taq DNA polymerase with a 2 min cycle at 95°C; 32 cycles 
of 30 s at 95°C, 30 s at 55°C, and 1 min at 72°C; a final extension time of 
7 min at 72°C; and samples are held at 4°C. An extension time of 1 
min/kb is assumed for this reaction.  
3. Following PCR, samples are run on a 1% agarose gel (See Section 5.4.2) 
for observation of PCR products of the anticipated size.  
4. Strains are now ready to be sequenced to verify the sequences of the 
inserted I-SceI gene and site. 
 
5.4.6 Design of DNA Oligos for Modification of a Chromosomal Locus 
To modify a locus distant from the DSB with oligos, a single oligo or a complementary 
pair can be used to generate the desired mutation. The following considerations should be 
made when determining which oligo(s) to use. First, while oligos as short as 40 bases in 
length can be used to efficiently transform the strain, the efficiency of targeting is 
increased as the length of oligo increases (up to 80-90 nt) [104]. Next, following 
generation of a DSB, there will be resection of each strand of the DNA away from the 
break in the 5’ to 3’ direction. The single oligo complementary to the intact strand 




suggested to determine which single oligo will be more favorable to use prior to 
performing the experiment. Finally, a pair of complementary oligos provides the most 
efficient repair template; however, in many cases the use of the single oligo 
complementary to the intact strand will be highly efficient at modifying the DNA and 
thus a complementary pair may not be necessary. 
 
5.4.7 Generation of the DSB 
In Section 5.4.1 a protocol for amplifying the CORE-I-SceI cassette is detailed. One of 
the primers introduces the 18-bp recognition site for the I-SceI endonuclease. After 
generation of a strain containing the integrated cassette and site, the I-SceI protein will be 
used to create a site-directed DSB at this chromosomal position. Expression of this gene 
is regulated by the GAL1 promoter, which is induced following addition of galactose to 
the medium. In the next two sections, we provide examples of repair assays which can be 
conducted using the galactose-induced system in haploid and diploid yeast strains. 
 
5.4.8 Repair Assay: Example at the trp5 Locus 
Here we provide an example of an assay for repair of a mutated, non-functional trp5 
marker which is located 10 kb downstream from the DSB site in a haploid strain with 
oligos that are used to repair the break and those which correct the sequence of trp5 (See 
Figure 5.1). Following correction of this marker, cells present a Trp
+
 phenotype which 
can be selected for on the solid medium lacking tryptophan. While targeted gene 




presentation of a selectable phenotype following correction enables more rapid screening 
of transformants. Further information on targeting at a non-selectable genetic locus is 
provided in Section 4 section below (See Note 5.6.8). 
1. Inoculate 50 ml of YPLac liquid medium with chosen strain into a 250-ml 
glass flask and shake vigorously at 30°C O/N (See Note 5.6.9). 
2. Add 5 ml of galactose from a 20% stock solution into the O/N culture for 
a final 2% galactose solution and continue to shake at 30°C for 7 h (See 
Note 5.6.10). 
3. Solutions 1 and 2 are prepared immediately prior to transformation.  
4. Transfer culture to a 50-ml conical tube and spin at 1562 x g for 2 min. 
5. Remove the supernatant and wash cells with 50 ml of sterile water and 
spin as stated previously. 
6. Remove the supernatant and resuspend cells in 5 ml of solution 1 and spin 
as stated previously. 
7. Remove supernatant and resuspend cells in 250-750 µl of solution 1. The 
pellet should be quite large. Depending on the dilution, this amount of 
cells is sufficient for up to approximately 30 transformations.  
8. Add 300 µl of solution 2 to each transformation tube. Mix briefly by 
vortexing. 
9. Incubate transformation tubes at 30°C for 30 min with shaking. 
10. Heat shock at 42°C for 15 min. 






Figure 5.1 Modification of a distant locus 10 kb downstream of the DSB site in 
haploid yeast cells. In this example, the starting strain contains a disrupted trp5 gene 
located approximately 10 kb downstream from the 18-bp recognition site for the I-SceI 
endonuclease. Following addition of galactose, which induces expression of the nuclease 
(indicated by the lightning bolt), a targeted DSB is generated at the I-SceI site and 5’ to 3’ 
resection occurs (indicated by the light gray dashed lines), leaving long 3’ single-stranded 
stretches of DNA. Next, oligos are transformed into the cells. These include an oligo 
complementary to both sides of the disruption in trp5 (as indicated by dashed lines 
between the oligos and genomic region), as well as oligos complementary to both sides of 
the break to repair it and simultaneously remove the CORE-I-SceI cassette. Single oligos 
or the complementary pair can be used for each position. An asterisk on the oligo used to 
correct the trp5 gene indicates the modification. Following transformation, the break is 
repaired while the target locus is modified (as indicated by the asterisk) to introduce the 





12. Remove the supernatant and resuspend cells well in 100 µl of sterile 
water. 
13. Plate a 105-fold dilution per strain to SD Complete solid medium. Plate all 
cells from each transformation tube on one synthetic dextrose complete 
medium lacking tryptophan (SC-Trp) plate using approximately 15 sterile 
glass beads and incubate at 30°C for 3-4 days until colonies appear (See 
Notes 5.6.12 & 5.6.13). 
 
5.4.9 Repair Assay: Example at the leu2 Locus 
Here we provide an example of an assay for repair of a mutated, non-functional leu2 
marker which is located 10 kb upstream from the DSB site in a diploid strain with the 
homologous chromosome being used to repair the break and oligos which correct the 
sequence of leu2 (See Figure 5.2). Following correction of this marker, however, cells 
present a Leu
+
 phenotype which can be selected for on solid medium lacking leucine. 
While targeted gene correction can be used at either a selectable or a non-selectable 
genetic locus, the presentation of a selectable phenotype following correction enables 
more rapid screening of transformants. Further information on targeting at a non-
selectable genetic locus is provided in Section 4 section below (See Note 5.6.8). 
1. Inoculate 50 ml of YPLac liquid medium with chosen strain into a 250-ml 
glass flask and shake vigorously at 30°C O/N (See Note 5.6.9). 




a final 2% galactose solution and continue to shake at 30°C for 7 h (See 
Note 5.6.10). 
3. Solutions 1 and 2 are prepared immediately prior to transformation.  
4. Transfer culture to a 50-ml conical tube and spin at 1562 x g for 2 min. 
5. Remove the supernatant and wash cells with 50 ml of sterile water and 
spin as stated previously. 
6. Remove the supernatant and resuspend cells in 5 ml of solution 1 and spin 
as stated previously. 
7. Remove supernatant and resuspend cells in 250-750 µl of solution 1. The 
pellet should be quite large. Depending on the dilution, this amount of cells is 
sufficient for up to approximately 30 transformations.  
8. Aliquot 50 µl of the cell suspension in microcentrifuge tubes and add 1 nmole 
of DNA oligos (heat-denatured for 2 min at 100°C, then immediately kept on 
ice prior to use). When using a single oligo to modify the chromosome distant 
from the break, 20 µl (at 50 µM or 50 pmol/µl) is used. When using a 
complementary pair of oligos, 10µl of each are used. 






Figure 5.2 Modification of a distant locus 10 kb upstream of the DSB site in diploid 
yeast cells. In this example, the starting strain contains a disrupted leu2 gene located 
approximately 10 kb upstream from the 18-bp recognition site for the I-SceI 
endonuclease. Following addition of galactose, a targeted DSB is generated at the I-SceI 
site, and 5’ to 3’ resection occurs (indicated by the light gray dashed lines), leaving long 
3’ single-stranded stretches of DNA. Next, oligos (here a single oligo is shown) are 
transformed into the cells with complementary to both sides of the disruption in leu2 (as 
indicated by dashed lines between the oligo and genomic region). Oligos which repair the 
break are unnecessary here as the homologous chromosome is available for strand 
invasion by the 3’ overhang (illustrated as the strand from the broken chromosome 
pairing with the complementary sequence of the homolog), which can lead to loss of the 
CORE-I-SceI cassette (as shown here). An asterisk on the oligo used to correct the leu2 




homologous chromosome while the target locus is modified (as indicated by the asterisk) 
to introduce the desired genetic modification in LEU2. 
10. Incubate transformation tubes at 30°C for 30 min with shaking. 
11. Heat shock at 42°C for 15 min. 
12. Collect cells by centrifugation at 2236 x g for 4 min. 
13. Remove the supernatant and resuspend cells well in 100 µl of sterile water. 
14. Plate a 105-fold dilution per strain to SD Complete solid medium. Plate all 
cells from each transformation tube on one synthetic dextrose complete 
medium lacking leucine (SC-Leu) plate using approximately 15 sterile glass 
beads and incubate at 30°C for 3-4 days until colonies appear (See Notes 
5.6.12 & 5.6.13). 
 
5.5 NOTES 
Note 5.6.1  
For medium preparation, deionized water is used. All other uses of the term “water” in 
this chapter, however, refer to water that has been sterilized by filtration or autoclaving. 
 
Note 5.6.2 
All solid media are autoclaved for at least 45 minutes at 121°C and then cooled to 55-






Unless otherwise noted, all solid media are to be stored at 4°C. YPD liquid and solid 
preparations are exceptions that can be stored at room temperature due to frequent use. 
Note 5.6.4 
Filter-sterilizing the 50% PEG 4000 solution can take up to one hour depending on the 
volume due to the high viscosity of the mixture. Autoclaving is generally used for 
sterilizing this solution. 
 
Note 5.6.5 
We use Ex Taq DNA polymerase for amplification of the cassettes as it consistently 
produces a higher yield of CORE cassette amplification than Taq DNA polymerase. 
 
Note 5.6.6 
For O/N growth, 50-ml conical tubes are used. Additionally, lids should not be capped 
tightly because S. cerevisiae is an aerobic species. Instead, loosely cover the tube and 
secure with tape. 
 
Note 5.6.7 
When the Kl-URA3 gene is inserted in the same orientation as the targeted gene, 
promoter occlusion may occur where interference from the target gene’s promoter during 
transcription may lead to delayed growth of Ura
+ 
colonies. If colonies on SC-Ura medium 
are not observed after 3 days the following alternative approach can be used: First, plate 
onto YPD and incubate at 30°C O/N. Then, replica-plate to G418- or hygro-containing 




replica-plate to SC-Ura and incubate at 30°C O/N. If possible, it is always preferred to 
have the Kl-URA3 marker gene oriented in the opposite direction relative to nearby 
promoters (See also [120]). 
 
Note 5.6.8  
This review provides examples of gene correction at a disrupted marker that is distant 
from the site of the DSB induced to stimulate the genetic modification. Our approach 
works well when the desired genetic modification results in a phenotypic change. If the 
desired genetic modification does not generate a change in the cell phenotype that can 
allow for easy selection, an alternative approach would be to screen by PCR aliquots of 
samples deriving from transformant cells, using primer(s) specific to the expected genetic 
modification. Following generation of a distant DSB, we have generally observed 




([52] and unpublished 
data). Using this as a guideline, we suggest testing by PCR 10 to 100 aliquots of cell 
samples deriving from 100 to 1,000 transformant cells. The aliquot(s) resulting positive at 
PCR should then be diluted and retested by PCR in order to narrow the number of cells 
containing the desired change. Such procedures should be repeated till the clone(s) with 
the desired mutation is identified. 
 
Note 5.6.9 
YPLac is used to provide a neutral carbon source for the cells prior to inoculation with 




grow much slower in this medium it is optimal to inoculate cells into YPLac at least 20-
24 h prior to the transformation. 
Note 5.6.10 
Depending on the distance between the site of the DSB and the chromosomal locus to be 
targeted, the amount of time needed for resection will vary. Given the observed resection 
rate in yeast of 1 nt/s [144], an incubation time of 7 h following addition of galactose 
should provide ample opportunity for both expression of the nuclease and resection to 
provide lengths of single stranded DNA more than 10 kb away. 
 
Note 5.6.11 
A single or complementary pair of oligos can be designed to simultaneously repair the 
DSB and remove the CORE-I-SceI cassette. This is advantageous as it allows for the 
markers present within the cassette to become available for generation of subsequent 
genetic modifications. If it is desired that the cassette remains in place, the DSB repairing 
oligo(s) can be designed accordingly. 
 
Note 5.6.12 
SD Complete medium is used here to determine the numbers of viable cells that survived 
the transformation. An appropriate dilution should be plated to ensure enough cells will 






It may be necessary to plate a dilution from the transformed tube to a selective medium. 
This depends on the expected numbers of colonies following transformation and is up to 
the determination of the researcher. We generally plate both a 10
-1
 dilution and all 








TO NICK OR NOT TO NICK: COMPARISON OF I-SCEI SINGLE- AND 
DOUBLE-STRAND BREAKS IN YEAST AND HUMAN CELLS 
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6.1 ABSTRACT 
Repair of a disrupted genetic locus can be accomplished through targeted gene correction 
using the cell’s HR machinery to introduce a corrected homologous sequence and replace 
the existing dysfunctional allele. While recombination is stimulated through generation of 
a site-directed DNA DSB, repair of the break through end-joining without using the 
homologous repairing template can lead to unwanted genomic changes such as 
chromosomal rearrangements. However, generation of an SSB, or nick, could lead to 
efficient gene correction without unwanted effects associated with a DSB as the SSB can 




we characterize a nicking variant of the I-SceI endonuclease in the yeast S. cerevisiae and 
in HEK-293 cells. While an I-SceI SSB stimulates gene targeting at lower levels than a 
DSB generated by the wild-type (wt) I-SceI endonuclease, SSB-driven gene correction is 
proficient both at the site and distant from the site of the break at the target genomic locus 
in yeast and follows a different mechanism than I-SceI DSB-driven correction. Moreover, 
an I-SceI SSB efficiently stimulates gene targeting at multiple genetic positions in human 
cells. These findings demonstrate the capability of the I-SceI nickase to stimulate 
recombination in multiple systems and could aid in further optimization of correction 
strategies for the treatment of genetic disorders.  
 
6.2 INTRODUCTION 
Gene targeting is a technique used to introduce desired genetic changes into the genome 
for purposes including genetic analysis through targeted deletion of a gene, addition of 
selectable markers, and gene replacement [36]. This process of genetic manipulation 
relies on HR to facilitate exchange of genetic sequences between the targeted 
chromosomal locus and a homologous template containing the desired mutation(s) [31]. 
Because many genetic disorders are caused by mutations in single genes, gene targeting 
has developed as a powerful technique capable of repairing the defective sequence 
through targeted replacement of the mutant allele with a functional copy [30,32,33]. 
However, because HR is naturally inefficient in many organisms, a DSB is often 
introduced within the vicinity of the targeted genomic locus in order to stimulate HR 




such as I-SceI and HO and which naturally have large cognate recognition sequences 
[44,49,51,53,131]. Additionally, designed endonucleases such ZFNs and TALENs, which 
can be designed to recognize highly-specific sequences, have widely been studied for 
their targeted gene correction potential [58,60,61,64,147]. Most recently, clustered 
regularly interspaced short palindromic repeats (CRISPR)/CRISPR associated (Cas) 
systems, which use RNA to target a homologous sequence for targeted cleavage and are 
naturally found in bacteria as part of the immune response, have shown great promise for 
further advancing gene targeting strategies [69,70]. However, while a DSB can efficiently 
stimulate HR up to 1,000-fold or more [49,51,53,54,131], the competing NHEJ pathway 
is favored in human cells which presents a major problem for gene targeting strategies 
[148]. Additionally, while an unrepaired DSB is lethal [149], repair of a DSB through 
NHEJ can lead to other harmful outcomes such as rearrangements and loss of essential 
genes [150]. Thus, other approaches to stimulate HR must be considered. 
 
One avenue for stimulation of HR for targeted gene correction is through the generation 
of a site-directed SSB, or nick. As opposed to double-stranded endonuclease, a nickase 
cleaves a single strand of the double-stranded DNA molecule which is thought to be safer 
than generating a DSB due to the propensity for the SSB to be re-ligated. Recent work 
has also shown that an SSB can lead to less off-site targeting than a DSB [77,78]. Studies 
in yeast and human cells have demonstrated that an SSB can facilitate gene targeting. 
These include employing a bona fide nickase, such as Gene II from the bacteriophage f1; 




zinc finger binding domains; and most recently through a CRISPR/Cas system using 
guide RNA (gRNA) to direct generation of an SSB at a target chromosomal locus 
[54,69,70,77,81-83,89,90]. Additionally, a nicking variant of I-SceI was generated which 
demonstrated in vitro activity different from I-SceI [108]. A lysine to isoleucine 
substitution at residue 223 was shown to abolish enzymatic cleavage activity at one 
strand of the 18-bp cognate I-SceI recognition site [108]. Despite this, no in vivo data on 
I-SceI K223I has been published demonstrating the capacity for an I-SceI SSB to increase 
gene targeting. 
 
Here, we show in multiple systems that an I-SceI SSB increases targeted gene correction 
over non-breakage in the yeast S. cerevisiae and in human cells. The study reveals that I-
SceI K223I acts as a nickase in vivo and can generate an SSB both at the site and at sites 
distant from the SSB in yeast. Additionally, it does so following a different mechanism 
than wt I-SceI. In yeast, genetic controls, cell cycle activity, and preference for different 
repairing molecules were assayed for this study. Moreover, we found that an I-SceI SSB 
can increase gene targeting in human cells both at a target plasmid locus as well as on the 
chromosome. These results aid in characterization of the I-SceI nickase and demonstrate 
its capacity for stimulating HR in different cell systems. Ultimately, these findings should 








6.3.1 Cleavage activity in vitro of the I-SceI nicking protein variant 
Different variants of the wt I-SceI protein were generated previously [108]. I-SceI K223I 
contains a substitution of the lysine at residue 223 with an isoleucine designed to cleave 
only one strand at the cognate 18-bp I-SceI recognition sequence, while I-SceI D145A is 
a variant generated by substitution of the aspartate at residue 145 with an alanine and in 
which cleavage activity is abolished [108]. A supercoiled plasmid containing the I-SceI 
recognition sequence was incubated with the wt, K223I, and D145A I-SceI proteins to 
show the in vitro cleavage activity of K223I and D145A relative to the cleavage activity 
of wt I-SceI. Within 20 minutes the plasmid was fully linearized by the wt I-SceI protein 
(Figure 6.1A), while the D145A variant failed to cleave the plasmid sequence up to 6 
hours later (Figure 6.1B). The K223I variant produced a nicked open circular product 
initially which was gradually converted into the linearized form (Figure 6.1C), indicating 
that the enzyme initially generates an SSB which later gets converted to a DSB. 
 
6.3.2 An I-SceI K223I break stimulates HR in yeast 
To test the in vivo capacity for I-SceI SSB-induced recombination in yeast, we generated 
plasmids containing the inducible GAL1 promoter regulating expression of the wt I-SceI, 
K223I, or D145A genes. For all of our repair assays, we determined HR stimulation 
based on the levels of transformants following expression of wt I-SceI or K223I over 
those following expression of D145A. We generated haploid yeast strains using the 
delitto perfetto method for site-directed mutagenesis and containing the plasmids 









Figure 6.1 DNA cleavage activities of the wt I-SceI, D145A, and K223I proteins.  
Supercoiled pBS I-SceI (E/H) plasmid DNA was incubated with (A) wt I-SceI, (B) the 
D145A mutant or (C) the K223I mutant for various lengths of time and the amounts of 
the nicked open circle (filled circles) and linear (open squares) reaction product DNAs 






We first looked at repair between direct repeats (Figure 6.2A). The LYS2 genomic locus 
is disrupted by the I-SceI recognition site which is flanked on either side by 90-bp direct 
repeats. Generation of a DSB between direct repeats triggers the single-strand annealing 
(SSA) HR pathway whereby, following resection of both ends in a 5’ to 3’ manner, 
annealing between the exposed single-stranded repeat regions and subsequent filling in of 
gaps leads to loss of the sequence between the repeats as well as one of the repeats itself 
[43]. With our system this would lead to reconstitution of the lys2 gene, thus we expected 
a greater number of Lys
+
 colonies with the DSB than with the non-break control. 
Following expression of wt I-SceI and generation of the DSB, recombination was 
stimulated more than 2,000-fold (p<0.0001). While the frequency was much lower 
following expression of K223I compared to wt I-SceI (1,000-fold less), there was a small 








Figure 6.2 An I-SceI K223I break stimulates HR between direct repeats in yeast. (A) 
Scheme showing disrupted yeast chromosomal locus containing the I-SceI recognition 
sequence within 90-bp direct repeats (arrows). The position of the SSB is indicated 
(“Nick”). (B) Levels of Lys
+
 recombinants following expression of wt I-SceI (dark blue 
bars labeled “DSB”), K223I (orange bars labeled “SSB”), or D145A (yellow bars labeled 
“Non-break”) in RAD51 wild-type (left) or mutant (right) strains are presented as the 







Next, we looked at repair using oligos (Figure 6.3A). The genomic TRP5 locus was 
disrupted by insertion of the I-SceI recognition site. Synthetic DNA oligos 80-bp in 
length were designed with homology to either side of the disruption such that they could 
restore the sequence of the gene if used as a repair template, as described in Chapters 2 
and 3. Previously, it was shown that oligos can efficiently repair a genetic region in yeast 
following generation of a DSB [53]. Using either of the single oligos (TRP5.80F (F), 
corresponding to the sense strand of the gene, and TRP5.80R (R), representing the 
antisense sequence) or the complementary pair, an increase in recombination at the trp5 
locus was observed (Figure 6.3B, left). Repair of the DSB was efficient for the 
complementary pair (190-fold increase, p≈0.0022) as well as for the single-stranded F or 
R oligo (80-fold increase, p≈0.0022, or 160-fold increase, p≈0.0022, respectively). With 
the K223I break, an increase in recombination frequency was also observed following 
transformation with oligos F, R, and the F+R pair (up to 9-fold increase for F, p≈0.0022; 
8.2-fold for R, p≈0.0022; and 4.5-fold for pair, p≈0.0087, respectively). Using the 80-
mers, recombination with K223I was 3-10% as efficient as with wt I-SceI. Additionally, 
there was no single strand bias for repair of either type of break with the nick site 
positioned in the “Crick” (p≥0.1797) (Figure 6.3B, left) or “Watson” (p≥0.3776) (Figure 








Figure 6.3 DNA oligos can efficiently be used to repair an I-SceI K223I break. (A) 
Scheme showing disrupted yeast chromosomal locus containing the I-SceI recognition 
sequence. The position of the SSB is indicated (“Nick”). F = oligo complementary to the 
anti-sense strand of the gene (indicated by dashed gray lines). R = oligo complementary 
to the sense strand. (B-D) Levels of Trp
+
 transformants following expression of wt I-SceI 
(dark blue bars labeled “DSB”), K223I (orange bars labeled “SSB”), or D145A (yellow 
bars labeled “Non-break”) using either of the single or the pair of oligos to repair the 
break. All data are presented as the median with range (n≥5). (B) Comparison of the 
orientation of the site when an SSB is generated on the bottom (“Crick”, left) or top 
(“Watson”, right) chromosomal strand. (C) Levels of transformants in RAD51 wild-type 
(left) or mutants (right) strains when the SSB is generated on the “Crick” strand. (D) 
Levels of transformants when cells were asynchronous (left) or arrested in G1 (right) 











Figure 6.3 (continued) 
 
Figure 6.3 (continued) 
 
 
6.3.3 Repair of a K223I break in yeast follows different genetic rules than for wt I-SceI 
Our in vitro experiment demonstrated that I-SceI K223I efficiently generates a nick but 
also can form a DSB at the I-SceI recognition site following prolonged incubation 
(Figure 6.1). In order to determine if the capacity of the K223I at stimulating gene 
correction was directly due to its nicking activity rather than its inefficient DSB activity, 
we looked into the requirements first of the strand invasion protein Rad51. DNA repair 
for lys2 direct repeat recombination and gene correction by oligos at the trp5 locus by the 




stimulated following its deletion [151], therefore with a DSB we expected an increase in 
direct repeat recombination as well as with ss oligo-driven gene correction in rad51 
mutants. The frequency of Lys
+
 colonies increased 1.5-fold (p<0.0001) in the rad51 
mutant background compared to RAD51 wt cells following expression of wt I-SceI 
(Figure 6.2B, right). A 1.8-fold increase (p≈0.0001) was observed for the non-break 
control, as expected due to short length of the closely-spaced direct repeats [151,152]. 
There was no difference in levels with the K223I break (p≈0.4302).  
 
Similar to the genetic requirements for repair between direct repeats, oligo-mediated 
DNA repair of a DSB is both RAD51-independent and in fact stimulated following its 
deletion [52]. Accordingly, we observed a 2.9- to 8.1-fold increase in Trp
+
 colonies 
(p≤0.0043) in rad51 mutants (Figure 6.3C, right). We observed the opposite for the 
K223I nick for which we recorded a significant decrease between 9.1- to 34-fold 
(p≈0.0022). To demonstrate that the nicking activity of K223I, rather than its low DSB 
activity, could be the stimulus for the observed Rad51-dependent gene correction by 
oligos, we compared gene correction efficiency by K223I with that for wt I-SceI using an 
amount of galactose that yielded frequencies of gene correction approximately equal to 
those observed for K223I in 2% galactose (Figure 6.4, left, light blue bars compared to 
yellow). Even at these frequencies (10-fold increase for F, p≈0.0043, and 4.2-fold 
increase for R, p≈0.0022, respectively) deletion of RAD51 stimulated recombination (3.6-
fold increase for F, p≈0.0152, and 2.9-fold increase for R, p≈0.0411, respectively) 
(Figure 6.4, right). These results are consistent with direct SSB-stimulated gene 




of K223I. These findings indicate that the K223I break is different from one generated by 





Figure 6.4 Recombination frequencies in RAD51 and rad51 null strains upon 
expressing wt I-SceI using low galactose concentrations. Reducing the amount of 
galactose in solution lowers levels of recombination following expression of wt I-SceI 
(“DSB (0.02%)”, light blue bars, compared to “DSB (2%)”, dark blue bars). Standard 
final concentrations of galactose in solution are 2%, while a 0.02% final concentration 
brought frequencies of recombination following expression of wt I-SceI down to 
frequencies previously observed following expression of K223I (fold increase determined 
by comparing light blue bars on left to non-cleavage control (“Non-break”) in yellow 






We next looked at repair in cells transformed after being arrested in the G1 phase of the 
cell cycle. We expected the frequencies of transformants would be lower following 
generation of a DSB due to the greater activity of NHEJ in G1. Following arrest in G1 
with α-factor, we expressed wt I-SceI, K223I, and D145A and then transformed trp5 
strains with the TRP5.80F and TRP5.80R 80-mers. Frequencies of Trp
+
 colonies 
significantly decreased up to 12-fold following expression of wt I-SceI in G1-arrested 
cells (p≤0.0087). Differently, frequencies were unaffected following K223I expression 
(p≥0.0649) (Figure 6.3D, right).  
 
6.3.4 An I-SceI K223I SSB stimulates HR at the site of the break in human cells 
We also tested recombination at the site of the break in human cells. We generated 
plasmids expressing wt I-SceI, K223I, or D145A under a strong CMV/CBA hybrid 
promoter modified from a previous study [60]. Each of these plasmids, a vector 
containing the I-SceI site within a disrupted target locus, and 80-bp synthetic DNA oligos 
were transiently co-transfected into HEK-293 cells as described in Chapter 4. The target 
plasmid loci, GFP or DsRed2 (referred to as RFP), were disrupted by an insert which 
includes the 18-bp recognition sequence for I-SceI (Figure 6.5A). F and R oligos 
(GFP.80F and GFP80.R for GFP or DsRed2.80F and DsRed2.80R for RFP) were 





depending on the marker, which were measured through fluorescence-activated cell 
sorting (FACS) approximately 8-10 days post-transfection. For both constructs, the F 







Figure 6.5 An I-SceI K223I SSB can stimulate recombination in human cells. (A) 
Scheme showing disrupted RFP plasmid locus or disrupted GFP plasmid or 
chromosomal locus. The position of the SSB is indicated (“Nick”). F = oligo 
complementary to the anti-sense strand of the gene (indicated by dashed gray lines). R = 
oligo complementary to the sense strand. (B-D) Levels of fluorescent cells following 
expression of wt I-SceI (dark blue bars labeled “DSB”), K223I (orange bars labeled 
“SSB”), or D145A (yellow bars labeled “Non-break”) using either of the single oligos to 
repair the break. All data are presented as the median with range. (B) Recombination at 
the RFP target plasmid locus (n=6). (C) Recombination at the GFP target plasmid locus 














At the RFP plasmid locus, higher than expected numbers of RFP
+
 cells (per 100,000 cells 
median=5 (5-5) for F and median=3 (2-6) for R) were detected for the negative control in 
which the target locus and either repairing oligo was provided (no-enzyme control, data 
not shown). All other negative controls produced <1 fluorescent cell per 100,000 cells 
(<0.25-0.5, data not shown). Despite this level of background for the no-enzyme control, 
the DSB stimulated repair at the RFP locus using either F or R (13-fold increase, 
p≈0.0131, and 26-fold increase, p≈0.0139, respectively) (Figure 6.5B). Over the non-
break control, levels were even higher (27-fold increase for F, p≈0.0050, and 39-fold 
increase for R, p≈0.0048, respectively). While there was no significant increase over the 
no-enzyme control using either oligo for repair of the SSB (p≥0.4500) or over the non-
break control with F (p≈0.1215), the SSB did stimulate recombination at RFP using the R 
oligo 2-fold (p≈0.0423). At this plasmid locus, the SSB was ~5% as efficient as the DSB.  
 
At the GFP plasmid locus, all negative controls produced <1 fluorescent cell per 100,000 
cells (<0.33-1). The DSB stimulated recombination using F or R (647-fold increase, 
p<0.0001, and 228-fold increase, p<0.0001, respectively) (Figure 6. 5C). No increase 
was observed for repair of the SSB with F (p>0.9999) but there was a significant 12-fold 
increase with R (p≈0.0078). At this plasmid locus, the SSB was ~5% as efficient as the 
DSB.  
 
We then looked at repair on the chromosome (Figure 6.5A). The cell line 658D is a 
monoclonal modified HEK-293 cell line in which a stably integrated copy of the same 




genome [60]. We transfected 658D cells with the plasmid expressing the I-SceI variant 
along with either F or R and measured fluorescence approximately 8 days later. All 
negative controls produced <1 fluorescent cell per 100,000 cells (<0.14-1). The DSB 
stimulated recombination using F or R (330-fold increase, p≈0.0002, and 77-fold 
increase, p<0.0001, respectively) (Figure 6.5D). Similar to the findings at the GFP 
plasmid locus, no increase was observed for repair of the SSB with F (p≈0.0769) but 
there was a significant 12-fold increase with R (p≈0.0004). On the chromosome at this 
target GFP locus, the SSB was ~16% as efficient as the DSB at stimulating 
recombination. At the GFP plasmid and chromosomal loci there was a bias in favor of 
the F oligo for the DSB (p<0.0001) while the R oligo was favored for the SSB (p≈0.0078 
and p≈0.0334, respectively). No strand bias was observed at the RFP locus for either 
(p≈0.6991 and p≈0.3743, respectively). 
 
6.3.5 An I-SceI K223I SSB stimulates HR at distant loci in yeast 
Previously it was shown that an I-SceI DSB can stimulate HR at a distant locus both 
upstream and downstream from the site of the break in yeast [52]. In that study, a strand 
bias in favor of the correcting oligo complementary to the strand 3’ of the DSB was 
observed due to the availability of that single-stranded DNA for annealing by the oligo 
following 5’ to 3’ resection [52]. We sought to determine if an I-SceI SSB several kb 
distant from the genomic locus to be corrected could also stimulate HR at that locus and 
if any strand bias could be observed by using the system described in Chapter 5. We 
generated diploid yeast strains in which a cassette containing the wt I-SceI, K223I, or 




integrated approximately 10 kb upstream or downstream from the TRP5 locus, which was 
disrupted by a 31-bp insert described previously [52] (Figure 6.6A). In both constructs, 
the I-SceI site was integrated in both orientations at the same chromosomal position such 
that the SSB would be generated on the top (“Watson”) or bottom (“Crick”) 
chromosomal strand. The TRP5.80F (F) and TRP5.80R (R) oligos used for repair at the 
site of the break were used to repair the trp5 locus in these systems.  
 
In the upstream system, the DSB stimulated recombination 7.1- to 35-fold with the F, R, 
and complementary pair of oligos (p≈0.0286) (Figure 6.6B). The SSB stimulated 
recombination 1.7- to 5.2-fold (p≈0.0286) using both of the single or the complementary 
pair of oligos except with the F oligo in the “Crick” construct (p≈0.0571) (Figure 6.6B). 
A strand bias in favor of the R oligo was observed following generation of the DSB in 
both orientations (p≈0.0286), while no strand bias was observed with the SSB for either 
the F or R oligo (p≥0.0571). In the downstream system, the DSB stimulated 
recombination 5.1- to 17-fold with the F, R, and complementary pair of oligos 
(p≈0.0286) (Figure 6.6C). The SSB stimulated recombination 2.3- to 2.8-fold with the 
single and complementary pair of oligos in the “Watson” construct (p≈0.0286), but no 
increase in transformants was observed in the “Crick” construct (p≥0.0571). A strand bias 
in favor of the F oligo was observed for the DSB in both orientations (p≈0.0286), while 
no strand bias was observed following generation of the SSB for either the F or R oligo 
(p≥0.4857). At distant loci in these systems, the SSB was 5-50% as efficient as the DSB 






Figure 6.6 An I-SceI K223I SSB stimulates HR at distant loci in yeast. (A) Scheme 
showing disrupted TRP5 chromosomal locus and CORE-I-SceI cassette inserted 10 kb 
upstream or downstream in diploid yeast cells. Black box indicates the position of the I-
SceI recognition sequence. F = oligo complementary to the anti-sense strand of the gene 
(indicated by dashed gray lines). R = oligo complementary to the sense strand. (B-C) 
Frequencies of Trp
+
 transformants following expression of wt I-SceI (dark blue bars 
labeled “DSB”), K223I (orange bars labeled “SSB”), or D145A (yellow bars labeled 
“Non-break”) using either of the single or the pair of oligos to repair the break. All data 
are presented as the median with range (n≥5). (B) Frequencies of transformants when an 
SSB will be generated on the bottom (“Crick”, left) or top (“Watson”, right) 
chromosomal strand 10 kb upstream from the trp5 locus. (C) Frequencies of 
transformants when an SSB is generated on the top (“Watson”, left) or bottom (“Crick”, 













6.3.6 An I-SceI DSB, but not an I-SceI SSB, stimulates HR at distant loci in human cells 
To determine if the DSB or SSB could stimulate HR at distant loci in human cells, we 
generated a plasmid containing two disrupted fluorescent protein markers, GFP and RFP. 
The disruptions in each gene contain unique sites which can be used to generate a break. 
Following transfection with an oligo designed to restore the sequence of the marker in 
which the break was not generated, we could determine if the distant break was able to 
stimulate HR. Specifically, the disruption in the RFP locus contains the 18-bp I-SceI 
recognition site which is located approximately 2.3 kb from the disruption in GFP 
(Figure 6.7A). We transfected this plasmid; a plasmid expressing wt I-SceI, K223I, or 
D145A; and either of the GFP-correcting oligos into HEK-293 cells and measured green 
fluorescence through FACS approximately 8 days later. All negative controls produced 
<1 fluorescent cell per 100,000 cells (<0.25-1). While no increase in fluorescent cells was 
observed with the SSB using either oligo as a repair template (p≥0.2731) or with the DSB 
using R (p≈0.0906), a 9.6-fold increase with the DSB and the F oligo was observed at the 
GFP locus (p≈0.0177) (Figure 6.7B). We also generated a distant break in vitro ~2 kb 
from either GFP or RFP, but no significant increases were observed at either loci (data 






Figure 6.7 An I-SceI DSB but not SSB stimulates HR at a distant plasmid locus in 
human cells. (A) Scheme showing disrupted GFP plasmid locus 2 kb distant from the I-
SceI recognition sequence (black box). F = oligo complementary to the anti-sense strand 
of the gene (indicated by dashed gray lines). R = oligo complementary to the sense 
strand. (B) Frequencies of GFP
+
 cells following expression of wt I-SceI (dark blue bars 
labeled “DSB”), K223I (orange bars labeled “SSB”), or D145A (yellow bars labeled 
“Non-break”) using either of the single oligos to correct the GFP gene located 2 kb 





The ability to activate the HR machinery through generation of a site-directed break 
enables targeted correction of genes if a homologous repairing template is provided. 
While this is most often accomplished following generation of a DSB, the potential for 
off-site targeting and genomic rearrangements that accompany non-homologous repair of 
the break is great [150]. Though designed nucleases, such as ZFNs and TALENs, can be 
optimized for highly-specific recognition of a genomic locus, the sequence constraints for 
such precision may limit the availability of suitable target regions [153,154]. Conversely, 
the emergence of designed nickases, such as engineered variants of natural 
meganucleases as well as zinc finger nickases, as an alternative means of stimulating HR 
with less off-site targeting holds great promise for gene targeting and correction [77,81-
83,90]. With this study, we aimed to characterize a novel variant of wt I-SceI, I-SceI 
K223I, which has been shown in vitro to preferentially cleave the 18-bp I-SceI 
recognition site in only one specific position [108]. While wt I-SceI has been widely-used 
to demonstrate the capability of DSB-driven gene targeting, no in vivo studies prior to 
this have explored the capacity for an I-SceI SSB to stimulate HR. We demonstrate here 
that I-SceI K223I generates a nick which can trigger the HR machinery in yeast and in 
human cells. Additionally, by directly comparing wt I-SceI and K223I in various assays, 
we demonstrate that the lesions are repaired in different ways. 
 
First, at the site of the break in yeast we observed an increase in recombinants following 
expression of K223I (Figure 6.2B and Figure 6.3B). While frequencies compared to wt 




to 9-fold increase in repair with K223I in yeast cells. In human cells an up to 12-fold 
increase was also observed at the site of the nick at multiple plasmid loci and even on the 
chromosome (Figure 6.5, panels B, C, and D). These findings demonstrate that an I-SceI 
K223I nick can activate HR in vivo, but they do not rule out the likelihood of this 
stimulation being due to an inefficient DSB. To explore this possibility, we looked into 
the requirement for the Rad51 recombinase.  
 
Recombination between direct repeats and gene correction by oligos at the site of the 
break in yeast stimulated by an I-SceI DSB not only does not require Rad51 but 
frequencies in fact increase in rad51 mutants (Figure 6.2B and Figure 6.3C). However, 
there was no change with K223I in the direct repeat system (Figure 6.2B) and gene 
correction frequencies significantly decreased with the oligo assay, indicating a strong 
dependence on a strand exchange reaction for oligo-mediated repair with this protein 
(Figure 6.3C). The dependence on Rad51 is not due to a low level DSB being generated 
by I-SceI K223I as reducing the recombination-inducing activity of the DSB by lowering 
expression of wt I-SceI still stimulated recombination in the absence of Rad51 (Figure 
6.4). Thus, we concluded that K223I generates an SSB in vivo which is repaired in a 
different manner than the I-SceI DSB. Additionally, while DSB repair frequencies 
significantly decreased when cells were transformed following G1 arrest, likely due to 
inactive resection in this stage of the cell cycle, there was no difference in recombination 
frequency following induction of the I-SceI SSB (Figure 6.3D), also indicating that the 
SSB-induced recombination is not due to an initial DSB. Finally, in human cells different 




(Figure 6.5, panels C and D). Together, these findings indicate differences in the ways wt 
I-SceI and I-SceI K223I stimulate recombination.  
 
We also tested whether I-SceI SSB could trigger HR at sites distant from the break in 
yeast and human cells. For gene targeting to be successful, the recombination machinery 
must be activated, but this requires generation of a break which is often accomplished 
through expression of a nuclease with sequence recognition near the targeted genomic 
locus. However, the sequence specificity of these enzymes may limit the region in which 
a suitable break may be generated. For example, ZFNs and TALENs require a spacer 
region between the DNA recognition sequences for each nuclease of the pair; however, 
the most preferential sequence for these nucleases may be located several kb away from 
the targeted locus to be corrected. If it is possible to generate the distant break while still 
triggering the HR machinery, then gene correction approaches could explore regions 
within this wider window as target sites for cleavage. While this has been demonstrated 
in yeast following generation of a DSB [52], to our knowledge the potential for 
correction at a genomic locus distant from an SSB has not been explored until this study. 
Following generation of the SSB in yeast, we observed a significant increase in 
recombinants when the break was generated both 10 kb upstream or downstream from 
the genomic locus targeted for correction (Figure 6.6, panels B and C left). Additionally, 
while a strand bias in favor of the oligo complementary to the strand 3’ of the break was 
observed for after generation of the DSB, no bias was observed in any system for 
following SSB generation for the distant assays. Despite these findings, an I-SceI SSB 




though an I-SceI DSB generated approximately 2 kb away was able to trigger the event. It 
may be possible to facilitate distant modification in human cells through mutation of 
53bp1 or Rif1, which function together to protect DNA ends from resection [155,156], as 
inactivation of this process would enhance DNA resection and expose sections of ssDNA 
for complementary pairing with an oligo. 
 
Our work demonstrates that expression of the I-SceI K223I variant in yeast and human 
cells stimulates recombination in these cells and that the molecular path by which this 
enzyme stimulates recombination is different from that driven by wt I-SceI. We propose 
two general models for I-SceI SSB-driven gene targeting by oligos. In the first model, an 
oligo can be used as a repair template to fix this SSB. As Rad51 is necessary for repair of 
the SSB, duplex invasion must be a required step (Figure 6.8 panels A and B). In the 
second model, the oligo is used to repair the break after collapse of the fork during 
replication. Again, invasion into the resulting duplex is crucial for repair of the lesion 
(Figure 6.8C). Additionally, while gene targeting following generation of a distant break 
in human cells can be accomplished (at least within a short window) through generation 
of DSB, studies should explore whether other nickases could trigger HR at distant loci in 
human cells. Ultimately, while the SSB does not result in a great level of stimulation at 
the site of the break, it does stimulate significant recombination and provides further 
evidence that SSB-driven gene targeting is a viable mechanism through which targeted 





Figure 6.8 Model for I-SceI K223I SSB-driven HR using single-stranded oligos. (A) 
Recombination using the oligo complementary to the intact strand. After the SSB is 
generated, the oligo (red arrow) anneals to the complementary strand, creating a 
mismatch which may produce a bulky lesion. This mismatch is processed, resulting in a 
gap which can be filled using the oligo sequence (red star), transferring it to the genome. 
The 3’ strand of the break may then invade the duplex following unwinding. Then the 3’ 
end is extended. (B) Recombination using the oligo complementary to the nicked strand. 
After the SSB is generated, the oligo sequence (red star) can be copied as it is used to 
extend the 3’ end. This extended end may invade the duplex at the 5’ end of the break. 
The 3’ end is then extended further. (C) Recombination following collapse of the 
replication fork. After the SSB is generated, it persists until encountered by the 
replication fork. Following fork collapse, resection of the 5’ ends (indicated by light gray 
dashed lines) produces single strands. Next, duplex formation involving annealing of the 
oligo allows for invasion by the 3’ replicating end (dark gray). The 3’ end copies the 
















6.5 MATERIALS AND METHODS 
6.5.1 Cleavage activity 
The double-strand and single-strand DNA cleavage activities of wild-type I-SceI and the 
K223I and D145A variants were analyzed by a kinetics assay using a supercoiled plasmid 
(pBSI-SceI (E/H)) containing a single wild-type I-SceI recognition sequence.  Reaction 
mixtures contained I-SceI cleavage buffer (10 mM Tris-HCl (pH 8.8), 1 mM DTT, and 
0.1 mg/ml BSA), pBS-I-SceI (E/H) supercoiled plasmid DNA (2.5 nM), and purified 
wild-type, K223I or D145A I-SceI (100 nM).  Reactions were initiated by the addition of 
MgCl2 (15 mM), and the mixtures were incubated for various lengths of time at 30°C 
before being halted by the addition of EDTA (100 mM).  Supercoiled, open-circle and 
linear DNAs were resolved by gel electrophoresis on a 0.8% agarose gel.  Gels were 
stained with ethidium bromide, and the fluorescence intensities of the DNA bands were 
determined using a Kodak EDAS 290 imager.  
 
6.5.2 Yeast plasmids  
Plasmid pGSHU, described previously [53], contains the CORE-I-SceI cassette (wt I-SceI 
gene under the GAL1 promoter, hygromycin resistance gene, the counterselectable 
KlURA3). Plasmids pGSHU-K223I and pGSHU-D145A are derivatives of pGSHU and 
contain the I-SceI K223I and I-SceI D145A genes, respectively, which were previously 
described by Niu et al. [108] to demonstrate nicking or non-cleaving in vitro activity, 
respectively, under the GAL1 promoter in addition to the hygromycin resistance gene and 
KlURA3. The resulting cassettes are referred to as CORE-wtI-SceI, CORE-K223I, and 




Plasmid pAG7 [54] is a yeast expression vector containing the GAL1 promoter, Gene II 
gene, and selectable LEU2 marker. Plasmids pAG7-wtI-SceI, pAG7-K223I, and pAG7-
D145A, are derivatives of plasmid pAG7 in which the Gene II gene was replaced with 
the wt I-SceI, K223I, or D145A gene, respectively.  
 
Mutagenesis and cloning information are provided as supporting information (Appendix 
B). 
 
6.5.3 Yeast strains 
Strains used for the direct repeat assay are derivatives of FRO-830 (MATα leu2-3,112 
ade5-1 his7-2 ura3Δ trp1-289 [lys2::Alu-DIRLEU2-lys2Δ50]) [52] and contain a 27-bp 
insertion comprised of two stop codons and the 18-bp I-SceI site in lys2 within 90-bp 
direct repeats flanking either side of the insertion. Strains were generated as previously 
described [102-104,120]. Strains SAS-74 and -75 contain plasmid pAG7-wtI-SceI, -77 
and -149 contain plasmid pAG7-K223I, and -142 and -143 contain plasmid pAG7-
D145A, respectively. Strains SAS-174 and -175 contain plasmid pAG7-wtI-SceI, -176 
and -177 contain plasmid pAG7-K223I, and -178 and -179 contain plasmid pAG7-
D145A, respectively, and are rad51 mutants in which RAD51 is replaced with the kanMX 
cassette. 
 
Strains used for repair at the site of the break are derivatives of FRO-1 (MATα ade5-1 
his7-2 leu2-3,112 ura3-52) [52] and contain one stop codon and the I-SceI site within a 




For most assays, the site is oriented such that the I-SceI SSB is on the bottom, or “Crick”, 
chromosomal strand. The mating type of these strains was switched to mating type a to 
allow for cell cycle arrest with α-factor. Strains SAS-227 and -228 contain plasmid 
pAG7-wtI-SceI, -229 and -230 contain plasmid pAG7-K223I, and -231 and -232 contain 
plasmid pAG7-D145A, respectively, and are mating type a. Strains SAS-235 and -236 
contain plasmid pAG7-wtI-SceI, -237 and -238 contain plasmid pAG7-K223I, and -239 
and -240 contain plasmid pAG7-D145A, respectively, and are mating type a as well as 
rad51 mutants in which RAD51 is replaced with the kanMX cassette. For comparison of 
the orientation of the I-SceI site at the site of the break, strains were generated such that 
the SSB is made on the top, or “Watson”, chromosomal strand. Strains SAS-281 and -282 
contain plasmid pAG7-wtI-SceI, -283 and -284 contain plasmid pAG7-K223I, and -285 
and -286 contain plasmid pAG7-D145A, respectively, and are mating type α. Strains 
which are also mating type α and in which an SSB will be made on the “Watson” strand 
were used in order to make comparisons of the orientation of the site between isogenic 
strains. For these strains, a 26-bp disruption containing the 18-bp I-SceI site and two stop 
codons was inserted into trp5. Strains SAS-78 and -79 contain plasmid pAG7-wtI-SceI, -
80 and -148 contain plasmid pAG7-K223I, and -116 and -117 contain plasmid pAG7-
D145A, respectively, and are mating type α. 
 
Strains used for repair distant from the site of the break are derivatives of FRO-917 
(MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 trp5::INS31 lys2::Alu IR) [52] and contain a 
nonfunctional TRP5 gene disrupted by a 31-bp insert. Diploid strains SAS-150 and -151, 




D145A cassettes, respectively, positioned approximately 10 kb upstream from the 31-bp 
disruption in TRP5, and containing the I-SceI site oriented such that the SSB is made on 
the bottom, or “Crick”, chromosomal strand. Diploid strains SAS-215 and -217, -207 and 
-209, and -211 and -213 contain the CORE-wtI-SceI, CORE-K223I, and CORE-D145A 
cassettes, respectively, positioned approximately 10 kb upstream from the 31-bp 
disruption in TRP5, and containing the I-SceI site oriented such that the SSB is made on 
the bottom, or “Watson”, chromosomal strand. Diploid strains SAS-152 and -153, -154 
and -156, and -158 and -160 contain the CORE-wtI-SceI, CORE-K223I, and CORE-
D145A cassettes, respectively, positioned approximately 10 kb downstream from the 31-
bp disruption in TRP5, and containing the I-SceI site oriented such that the SSB is made 
on the bottom, or “Watson”, chromosomal strand. Diploid strains SAS-272 and -274, -
219 and -221, and -251 and -253 contain the CORE-wtI-SceI, CORE-K223I, and CORE-
D145A cassettes, respectively, positioned approximately 10 kb downstream from the 31-
bp disruption in TRP5, and containing the I-SceI site oriented such that the SSB is made 
on the bottom, or “Crick”, chromosomal strand. 
 
The CORE-wtI-SceI cassette used in this study was PCR amplified from plasmid pGSHU 
using primers described previously [53]. The CORE-K223I and CORE-D145A cassettes 
used in this study were amplified from plasmids pGSHU-K223I and pGSHU-D145A, 
respectively, using these same primers. The integration of the cassette into the yeast 
genome was carried out as previously described [53,120].  
 




strain construction information is provided as supporting information (Appendix B). 
 
6.5.4 Direct repeat repair 
For the assay to correct the non-functional lys2 locus, cells were grown overnight in 5 ml 
yeast extract-peptone-lactic acid (YPLac) liquid medium at 30°C with shaking. 
Appropriate dilutions of the overnight cultures were made, and cells were plated directly 
to synthetic complete medium lacking lysine (SC-Lys) containing 2% galactose to 
express GAL1-I-SceI and induce the break. Cells were also plated to synthetic complete 
(SC) medium to assess cell viability. 
 
6.5.5 Break induction and targeting using oligos 
Break induction and targeting with oligos were performed as previously described 
[112,120,136]. Briefly, for targeting at the trp5 locus, 50 ml of an overnight YPLac liquid 
culture was inoculated with galactose (2% final concentration, unless otherwise noted) 
and incubated with vigorous shaking at 30°C for 4 h (7 h for experiments involving 
modification distant from the break)  to express GAL1-I-SceI and induce the break. After 
incubation in galactose, cells were prepared for transformation. Transformation was done 
with 1 nmol of total oligo DNA. Sequences of oligos used to repair the trp5 gene are 
listed in Appendix B. Cells from each oligo transformation were diluted appropriately 
and spread directly to synthetic complete medium lacking tryptophan (SC-Trp) to select 
for oligo-mediated targeted gene correction of trp5 or to SC to assess cell viability. 
 




galactose was inoculated into the overnight culture prior to shaking at 30°C for 4 h. 
  
6.5.6 Cell cycle arrest 
Mating type a cells were arrested in G1 as follows: α-factor (US Biological, Marblehead, 
MA) was transferred into a 50 ml overnight culture of YPLac for a final concentration of 
0.4 μg/ml.  Cultures were incubated with vigorous shaking at 30°C for 2 h. Cells were 
sonicated and counted. After 2 h, >80% of cells were in G1. 
 
6.5.7 Human plasmids 
Plasmid p67 (a kind gift from M. Porteus, Stanford University) contains the I-SceI 
endonuclease gene regulated by a CMV/CBA hybrid promoter [60]. Plasmid p67-K223I, 
which contains the K223I gene, and plasmid p67-D145A, which contains the D145A 
gene, are derived from plasmid p67 and also contain the CMV/CBA hybrid promoter.  
 
Plasmid pGRdis contains two nonfunctional reporter genes, eGFP and DsRed2, both 
under the CMV promoter oriented opposite from each other and separated by a 300-bp 
spacer. Within eGFP there is a 148-bp insertion containing two stop codons, a unique 
XhoI site, and the recognition sequence for the HO endonuclease from S. cerevisiae. 
Within DsRed2 there is a 37-bp insertion containing two stop codons, a unique XbaI site, 
and the recognition sequence for I-SceI. Additionally, the recognition sequences of HO 
and I-SceI are located approximately 2.3 kb from each other. This plasmid was used for 
experiments assaying repair at the site of the break in DsRed2 as well as for the human 




Plasmid pA658 (a kind gift from M. Porteus, Stanford University) contains a GFP gene 
disrupted by a 35-bp insert containing a single stop codon, and the recognition site for the 
I-SceI endonuclease [60]. This plasmid was used for experiments assaying repair at the 
site of the break in GFP. 
 
Mutagenesis and cloning information are provided as supporting information (Appendix 
B).  
 
6.5.8 Human cell lines and culture 
HEK-293 cells were grown in Dulbecco’s modified Eagle’s medium, DMEM 
(Mediatech, Inc., Manassas, VA), supplemented with 10% heat-inactivated fetal bovine 
serum (Gemini, Bio-Products, West Sacramento, CA) and 1x penicillin/streptomycin 
(Lonza, Walkersville, MD). Cells were grown at 37°C in a 5% CO2 humidified incubator. 
Cell line 658D (kindly provided by M. Porteus, Stanford University) is a HEK-293 
derivative cell line containing a randomly integrated copy of the sequence of plasmid 
pA658 [60]. Cells were transfected using polyethylenimine (PEI, Polysciences, 
Warrington, PA) transfection reagent in 24-well plates at a density of ~50,000 cells per 
well as previously described [128]. In all transfection experiments in HEK-293 cells, 
plasmid DNA was used in the amount of 0.5 μg and oligo DNA was 1.5 μg, while 1 μg 
each of oligo and plasmid DNA was used for transfection experiments in 658D cells. In 
these experiments, the oligos and the plasmid were diluted in DMEM without 
supplements, vortexed in the presence of PEI, and then added to the wells 20 min later. 




Observer A1 microscope and an AxioCam MRm camera (Zeiss, Thornwood, NY). 
Frequencies of GFP
+
 cells were obtained 5-8 days following transfection by flow 
cytometric analysis using the BD LSR II Flow Cytometer (BD Biosciences, Sparks, MD). 
Frequencies of RFP
+
 cells were obtained 5-8 days following transfection by flow 
cytometric analysis using the BD FACS Aria Cell Sorter (BD Biosciences). 100,000 cells 
were counted for each sample. Sequences of oligos used to repair the GFP or DsRed2 
genes are listed in Table S1. 
 
6.5.9 Data presentation and statistics 
Graphs were created using GraphPad Prism 5 (GraphPad Software, Inc.). For all 
histograms, data are plotted as median values with the range shown. Statistical 










Gene targeting can be effectively used to alter a genomic sequence through targeted 
replacement of the existing allele with a homologous sequence. This relies on the natural 
HR machinery of the organism. In order to trigger this machinery DNA damage can be 
inflicted, most commonly through generation of a DSB. However, because of the dangers 
of generating this type of lesion, including the potential for GCRs and gene loss, other 
types of DNA damage have been investigated for their recombination-inducing potential. 
Notably, SSBs have been proposed to efficiently stimulate HR, an activity which has 
been demonstrated in yeast and human cells using multiple SSB-generating enzymes, or 
nickases [54,81]. Moreover, generation of an SSB is thought to be a safer approach for 
facilitating targeted gene correction because an SSB can be easily re-ligated and produces 
less local mutagenesis at the site of the break than a DSB [77,78]. 
 
In this study, we aimed to characterize a novel nicking protein, I-SceI K223I – which is 
an engineered variant of the I-SceI meganuclease [108]. Because we wanted to explore 
the possibility of I-SceI SSB-induced recombination in different organisms, we 
developed systems first in the yeast model organism and later in human cells. We also 




potential at different episomal or chromosomal loci and at positions near or distant from 
the site of the break.  
 
In yeast, strains were generated using the delitto perfetto system which allowed us to 
integrate the target recognition sequence for the I-SceI enzyme into a defined genomic 
locus using a two-step process. Strains were isogenic in order to directly compare a break 
generated by the I-SceI K223I nickase to a wt I-SceI DSB. In Chapters 2 and 3 we 
detailed the delitto perfetto strategy, optimized steps of the in vivo mutagenesis approach, 
established new protocols, and provided examples of the types of genomic modifications 
which could be made using this system. These examples include gene knockouts and 
knockins, both of which were techniques we used to build our constructs. For example, 
we knocked out RAD51 in order to demonstrate a genetic dependence on the recombinase 
for repair at the site of an I-SceI SSB; and the knockin approach was extensively used to 
introduce the I-SceI proteins and recognition sequence into the desired chromosomal 
locus. 
 
Three types of systems were used for our yeast studies. In the first, the LYS2 gene on 
chromosome II was disrupted by an insert containing the cognate 18-bp recognition 
sequence of I-SceI between 90-bp direct repeats. Following expression of the I-SceI 
variant and generation of the resulting break, the direct repeats could recombine to restore 
the sequence of the gene. The resulting phenotype was then used to score the 
recombination events and compare the I-SceI K223I break to that of wt I-SceI. In the 




chromosome VII. Following generation of the break, an exogenous repair template was 
introduced into the yeast cells. This template consisted of a single-stranded synthetic 
DNA oligo (or the complementary oligo pair) and was designed to have homology to 
either side of the disruption in trp5 such that through recombination it could “pop out” 
the intervening nucleotides and thus restore the sequence of the gene. Again, the resulting 
phenotype was used to score the recombination events and compare the SSB to the DSB. 
In the third system, the I-SceI recognition sequence was integrated into the genome ~10 
kb upstream or downstream from a disrupted trp5 gene on chromosome VII. Following 
generation of the distant break, oligos were introduced into cells and could recombine 
with the disrupted locus to restore the sequence of the gene. In Chapters 2, 3, and 5 we 
detailed the protocols used to test recombination at or distant from the site of the break in 
yeast, respectively. 
 
In our human cell system we tested recombination at the site of the break at an episomal 
or chromosomal target locus as detailed in Chapter 4. Much like in the yeast system, a 
target gene (RFP or GFP) on a plasmid was disrupted by an insert containing the 
recognition sequence for I-SceI.  Synthetic DNA oligos were designed with homology to 
either side of the disruption such that they could recombine at the target locus and restore 
the sequence of the gene, producing a selectable phenotype in the process. We also 
modified this system for an assay testing recombination at a target chromosomal locus 
using a cell line containing a stably integrated disrupted GFP locus [60]. Using these 
systems we were able to demonstrate the recombination potential of an I-SceI SSB in 




from the site of an I-SceI break in human cells. We generated a plasmid construct 
containing disrupted GFP and RFP genes located approximately 2 kb from each other. 
Each gene contains unique sites which can be cleaved by specific restriction enzymes and 
meganucleases. Following generation of a break at one locus, oligos transfected into the 
cells can recombine at the other genetic locus, restoring its sequence. The resulting 
phenotype can be quantified in order to determine the potential for the break to trigger 
recombination at the distant locus. Together these constructs and systems provide useful 
tools for testing the recombination potential of I-SceI breaks and could be modified for 
other enzymes to directly compare them, as well. 
 
 Using our systems for recombination between direct repeats and for gene correction by 
oligos, we first demonstrated that a break generated by the I-SceI K223I variant could 
trigger HR in yeast. In both of these systems the K223I break stimulated recombination 
significantly over the non-breaking control. Though the K223I variant was shown in vitro 
to generate an SSB at the cognate 18-bp recognition sequence [108], in vivo it was not 
clear if this would be the case. The in vitro studies demonstrated that the SSB was 
converted to a DSB following extended digest with the purified protein, therefore there 
was a possibility that the increased levels of repair we observed were not due to an I-SceI 
SSB but instead to a DSB. To examine if the mechanism by which the I-SceI SSB 
induced gene correction was different from that of the I-SceI DSB we deleted the RAD51 
recombinase gene in both the I-SceI SSB and DSB systems in yeast. Previously, deletion 
of RAD51 was shown to increase levels of repair of a DSB between direct repeats and 




into the corresponding sister chromatid [43,52]. We demonstrated that the break 
generated by I-SceI K223I had a different genetic requirement than the I-SceI DSB. 
Deletion of RAD51 had no effect on recombination between direct repeats, and with the 
oligo-mediated repair levels of correction significantly decreased following expression of 
the K223I variant in rad51 cells. These results indicated that recombination triggered by 
the I-SceI SSB is stimulated by a different mechanism than recombination promoted by 
the I-SceI DSB. Thus, we proposed that a nick can stimulate recombination without being 
converted into a DSB. Nevertheless, it was still possible that a low level of DSB 
formation, resulting from the I-SceI SSB being converted into a DSB at the time as 
revealed by our in vitro data (Figure 6.1), stimulates recombination in a Rad51-
dependent mechanism. If this hypothesis is true, we expected that reducing the expression 
of wt I-SceI so that it stimulated recombination to the same extent of K223I would have 
promoted recombination in a Rad51-dependent manner. On the contrary, when we 
lowered expression of wt I-SceI, we again observed an increase in recombinants in the 
absence of RAD51. These findings demonstrated that the break generated by I-SceI 
K223I was different from that generated by wt I-SceI, and we concluded that the I-SceI 
SSB made by I-SceI K223I directly stimulates recombination before the enzyme can 
convert the nick into a DSB.   
 
Though we determined the I-SceI K223I break is initially an SSB in the yeast 
chromosomal DNA, it still remains unknown if the lesion is subsequently converted into 
a DSB not by the I-SceI K223I enzyme but during replication. If the SSB persists until 




nick and generate a DSB [12]. As expected, we observed a significant decrease in 
transformants following expression of wt I-SceI, but this is likely due to the lack of 
resection while arrested in G1. Differently, we observed no change in transformants 
following expression of I-SceI K223I. These results further supported that stimulation of 
recombination by I-SceI K223I is not due to an inefficient DSB by the enzyme. 
Moreover, the G1 data could be explained by collapse of the fork as the cells progressed 
into S phase at the beginning of transformation, resulting in a 3-strand DSB which could 
then trigger recombination with the oligos. Together with the RAD51 findings, these 
results indicate that an initial SSB can trigger HR in yeast and that this may be a 
replication-dependent event.  
 
In the future, we could probe the DNA at different time points or during different stages 
of the cell cycle in order to demonstrate the condition of the lesion. We could also test 
other genetic requirements for repair of the I-SceI K223I SSB. Candidate proteins for 
mutation include those involved in the checkpoint response to stalled or collapsed 
replication forks such as Mec1, Tel1, Ddc2, and Rad53 (the yeast homologs of the human 
proteins ATR, ATM, ATRIP, and CHK2, respectively) [157-159]. Comparison of I-SceI 
SSB- to DSB-induced recombination activity in a mec1, tel1, ddc2, or rad53 mutant 
background could yield evidence of other genetic differences between repair of the two 
types of lesions. 
 
We also demonstrated that an I-SceI SSB can trigger recombination in human cells at 




chromosomal assays in HEK-293 cells, proving that SSB-driven recombination is not 
limited to specific genetic sequences. Furthermore, we observed opposite strand bias 
targeting at one locus both at the plasmid and chromosomal position when the oligo 
recombination was activated by an SSB rather than by a DSB. The F oligo was favored 
for repair of the DSB at the GFP target locus, while the R oligo was favored for repair of 
the SSB. These findings further reveal differences in repair of the different types of 
lesions. In order to explore the mechanisms underlying these biases, we could change the 
orientation of the I-SceI site such that the break generated by I-SceI K223I would be on 
the opposite strand. Alternatively, we could test the bias within our current system using 
another nicking variant designed to generate a break on the opposite strand.  
 
In addition to our findings in yeast and human cells that an I-SceI SSB can stimulate 
recombination at the site of the break, we demonstrated the capacity of the I-SceI SSB for 
modification at a position distant from the break. In yeast our results showed that an I-
SceI K223I SSB could trigger recombination at a genomic locus 10 kb away from the site 
of the break. Moreover, while a strand bias was observed in favor of the oligo 
complementary to the 3’ strand when an I-SceI DSB was generated, no strand bias was 
observed when the SSB was induced. These results again corroborated our findings that 
the I-SceI K223I lesion that promotes recombination is, in fact, an SSB as the same bias 
for the oligo complementary to the strand 3’ of the break would be expected if a DSB is 





While we demonstrated that the I-SceI SSB could trigger HR at a distant locus in yeast, 
we did not observe the same in human cells. It is possible that the SSB repair machinery 
was able to repair the lesion before any recombination with oligos could occur. We could 
test this hypothesis by inhibiting the poly(ADP-ribose) polymerase (PARP) family of 
proteins, which are involved in detecting and facilitating correction of SSBs [80], to 
determine if levels of recombinants increase following inhibition of SSB repair. In human 
cells an I-SceI DSB generated in vivo did show a minor increase in recombinants, though 
an in vitro break did not. Perhaps introducing linearized plasmid DNA into the cells 
simultaneously with the oligos hinders modification at the locus distant from the broken 
ends. This could be due to repair of the lesion before the oligos reach the target region.  
In the future we could test recombination at a distant locus on the chromosome in 
mammalian cells similarly to our in vivo plasmid assay for distant modification. 
Following expression of the protein inside the cells, the oligos may have a better chance 
to reach the target locus before the break is repaired. 
 
As gene targeting has advanced, numerous developments have been made to optimize 
approaches used for targeted gene correction. Overall, our findings demonstrate that an I-
SceI SSB can stimulate recombination in eukaryotic cells. While the nicking variant used 
generates breaks efficiently targeted for correction in our systems, future nickases could 
be designed with even greater nicking activity. However, our systems provide a 
foundation for the study of SSB-induced gene targeting and the findings herein should 






SUPPLEMENTARY MATERIALS FOR CHAPTER 2 
 
Table A.1 Preparation of 3 M NaOAc stock solution, pH 5.2, filter sterilized 
Add water to 500 ml 
 
Component Final concentration Amount/500 ml 




Table A.2 Preparation of 10x TE stock solution, pH 7.5, filter sterilized 
Add water to 500 ml 
 
Component Final concentration Amount/500 ml 
Tris  100 mM 6.06 g 




Table A.3 Preparation of 1 M LiOAc stock solution, filter sterilized 
Add water to 500 ml 
 
Component Final concentration Amount/500 ml 









Table A.4 Preparation of 50% PEG 4000 stock solution, filter sterilized 
Add water to 500 ml 
 
Component Final concentration Amount/500 ml 




Table A.5 Preparation of G418 stock solution, filter sterilized 
Add water to 50 ml 
 
Component Final concentration Amount/50 ml 
G418 50 mg/ml 2.5 g 
   
 
Table A.6 Preparation of Lyticase stock solution, stored in 1 ml aliquots 
Add water to 1 ml 
 
Component Final concentration Amount/1 ml 




Table A.7 Preparation of 20% Galactose stock solution, filter sterilized 
Add water to 1 L 
 
Component Final concentration Amount/1 L 







SUPPLEMENTARY MATERIALS FOR CHAPTER 6 
 
B.1 Yeast plasmid construction  
Plasmid pGSHU, described previously [102], contains the CORE-wtI-SceI cassette (wt I-
SceI gene under the GAL1 promoter, hygromycin resistance gene, the counterselectable 
KlURA3) and was used as a template to construct plasmids pGSHU-K223I and pGSHU-
D145A. Site-directed mutagenesis was conducted using the QuikChange II Site-Directed 
Mutagenesis Kit (Agilent Technologies, Inc., Santa Clara, CA). Point mutations were 
generated by primers I-SceI K223I.F (5’-GCAGATGATGTACATTCTGCCGAACACT 
AT) and I-SceI K223I.R (5’-ATAGTGTTCGGCAGAATGTACATCATCTGC) to make 
plasmid pGSHU K223I (AAAATT at I-SceI residue 233) or by primers I-SceI 
D145A.F (5’-ATACTGGTTCATGGCTGATGGTGGTAAAT) and I-SceI D145A.R (5’-
ATTTACCACCATCAGCCATGAACCAGTAT) to make plasmid pI-SceI D145A 
(GATGCT at I-SceI residue 145) variants described by Niu et al. [108]. Plasmids were 
rescued in Escherichia coli and confirmed by sequence analysis.  
 
Plasmids pAG7-wtI-SceI, pAG7-K223I, and pAG7-D145A were constructed as follows. 
Plasmid pAG7 [54] was digested with BamHI to excise the ~1.3 kb fragment containing 
the coding sequence of Gene II. A 750-bp fragment containing the coding sequence of 
the I-SceI gene from plasmids pGSHU, pGSHU-K223I, or pGSHU-D145A was 




GGTACATATGCATATGAAAAACATCAA) and pAG7 clone I-SceI.R (5’-CTAGAG 
GATCCCCGGGTACCGAGCTCGAATTCCCTTATTTCAGGAAAGTTTCGG) and 
cloned into the BamHI site of the digested pAG7 plasmid resulting in plasmids pAG7-
wtI-SceI, pAG7-K223I, or pAG7-D145A, respectively. Plasmids were rescued in E. coli 
and confirmed by sequence analysis. 
 
B.2 Yeast strain construction  
The strain FRO-830 (MATα leu2-3,112 ade5-1 his7-2 ura3Δ trp1-289 [ lys2::Alu-
DIRLEU2-lys2Δ50]) contains the CORE-wtI-SceI cassette and the 18-bp I-SceI site in 
lys2 within 90-bp direct repeats flanking either side of the cassette. Strains used for the 
direct repeat experiments are derivatives of FRO-830 and were generated as previously 
described [103,112,120]. Briefly, the entire CORE-wtI-SceI cassette was replaced with 
the full I-SceI site using oligos LYS2 I-SceI site.F (5’- CACTGGGTTTATCCATATGC 
CAAATTGAGCTAATAAATTACCCTGTTATCCCTAAAGAGAAGTGGATGGATT
TGGCAAACACAGTT) and LYS2 I-SceI site.R (5’-AACTGTGTTTGCCAAATCCAT 
CCACTTCTCTTTAGGGATAACAGGGTAATTTATTAGCTCAATTTGGCATATGG
ATAAACCCAGTG) to produce strain SAS-50. Plasmids containing the galactose-
inducible GAL1 promoter and variants of the I-SceI gene were then transformed into this 
strain to yield the following strains: SAS-74 and -75, which contain pAG7-wtI-SceI; 
SAS-77 and -149, which contain pAG7-K223I; and SAS-142 and -143, which contain 
pAG7-D145A. Additionally, in strain SAS-50 the entire coding region of RAD51 was 
replaced with the kanMX cassette conferring antibiotic resistance to G418 for the rad51 




peptone-dextrose (YPD) medium containing 200 μg/ml of G418 (Mediatech, Inc., 
Manassas, VA). Plasmids were transformed into the resulting strain to yield the following 
rad51 mutant strains: SAS-174 and -175, which contain pAG7-wtI-SceI; SAS-176 and -
177, which contain pAG7-K223I; and SAS-178 and -179, which contain pAG7-D145A. 
Leu
+
 transformants were selected for on synthetic complete medium lacking leucine (SC-
Leu) and subsequently maintained on this medium to retain the plasmid.  
 
The strain FRO-1 (MATα ade5-1 his7-2 leu2-3,112 ura3-52) contains the CORE-wtI-
SceI cassette and the I-SceI site within trp5. Strains used for repair at the site of the break 
are derivatives of FRO-1 and were generated as previously described [103,112,120]. 
Briefly, the entire CORE-wtI-SceI cassette was replaced with the full I-SceI site oriented 
such that a nick created by the I-SceI nickase is made on the bottom, or “Crick”, 
chromosomal strand, using oligos TRP5 I-SceI site. F (5’-GAAGTCTTCCCAGAATGT 
GGGATCGATTACCCTGTTATCCCTATGATGAAAGCGACAGCTTCATCAAAAC
CCTTTT) and TRP5 I-SceI site.R (5’- AAAAGGGTTTTGATGAAGCTGTCGCTTTC 
ATCATAGGGATAACAGGGTAATCGATCCCACATTCTGGGAAGACTT) resulting 
in strain SAS-59, or on the top, or “Watson”, chromosomal strand, using oligos TRP5 I-
SceI site opp.F (5’ –AAAAGGGTTTTGATGAAGCTGTCGCATGATGAATTACCCT 
GTTATCCCTAACGATCCCACATTCTGGGAAGACTTC) and TRP5 I-SceI site opp.R 
(5’ –GAAGTCTTCCCAGAATGTGGGATCGTTAGGGATAACAGGGTAATTCATC 
ATGCGACAGCTTCATCAAAACCCTTTT) resulting in strain SAS-278. Plasmids 
containing the galactose-inducible GAL1 promoter and variants of the I-SceI gene were 




SceI nick will be generated on the “Crick” strand: SAS-78 and -79, which contain pAG7-
wtI-SceI; SAS-80 and -148, which contain pAG7-K223I; and SAS-116 and -117, which 
contain pAG7-D145A. Strains in which the I-SceI nick will be generated on the 
“Watson” strand: SAS-281 and -282, which contain pAG7-wtI-SceI; SAS-283 and -284, 
which contain pAG7-K223I; and SAS-285 and -286, which contain pAG7-D145A. For 
strains containing the nicking orientation on the “Crick” strand, the mating type was then 
switched as follows: The coding region of the BAR1 gene was replaced with an amplicon 
containing the URA3 gene, and Ura
+
 transformants were selected on synthetic complete 
medium lacking uracil (SC-Ura), yielding strain SAS-182. Plasmid pHO-LEU2, which 
contains the mating type switching endonuclease HO regulated by the inducible GAL1 
promoter and selectable LEU2 marker, was then transformed into this strain and 
transformants were selected for on SC-Leu. Cells were then grown in yeast extract-
peptone-galactose (YPGal) liquid medium for one hour at 30°C to allow for expression of 
the HO protein and dilutions were plated to YPD solid medium. The resulting strain, 
SAS-193 (MATa ade5-1 his7-2 leu2-3,112 ura3-52, trp5::Cr-I-SceI site), and its 
derivative, SAS-205, in which the entire coding region of RAD51 was replaced with the 
kanMX cassette, were transformed with plasmids containing the galactose-inducible 
GAL1 promoter and variants of the I-SceI gene. Strains in which RAD51 is wt: SAS-227 
and -228, which contain pAG7-wtI-SceI; SAS-229 and -230, which contain pAG7-
K223I; and SAS-231 and -232, which contain pAG7-D145A. Strains in which RAD51 is 
replaced: SAS-235 and -236, which contain pAG7-wtI-SceI; SAS-237 and -238, which 




were grown on synthetic complete medium lacking leucine (SC-Leu) following 
transformation to maintain the plasmid. 
 
The strain FRO-917 is a derivative of BY4742 (MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 
trp5::INS31 lys2::Alu IR) and contains a nonfunctional trp5 gene disrupted by a 31-bp 
insert [52]. Strains FRO-872 [52], SAS-138, and -140 contain a CORE-wtI-SceI, CORE-
K223I, or CORE-D145A cassette (with the hygromycin resistance gene and I-SceI site on 
the “Crick” strand), respectively, which was amplified as a PCR product with primers 
10KbUP.IS (5-AGATAATTTACCCTTGCTTTAAGCTGCGTATATCAAGTGCATTT 
GCTGTCTAGGGATAACAGGGTAATTTCGTACGCTGCAGGTCGAC) and  
10KbUP.II (5’-TCGTTCGTTATCCGAAGCTGGCCAATTGATACAATTAATTGAC 
ATCAGCATTGGATGGACGCAAAGAAGT) and cloned approximately 10 kb 
upstream from the 31-bp insert in trp5. Strains SAS-199 and -200, -195 and -196, and -
197 and -198 contain a CORE-wtI-SceI, CORE-K223I, or CORE-D145A cassette (with 
the hygromycin resistance gene and I-SceI site on the “Watson” strand), respectively, 
which was amplified as a PCR product with primers 10KbUP.opp.IS (5’ –AGATAATT 
TACCCTTGCTTTAAGCTGCGTATATCAAGTGCATTTGCTGTCATTACCCTGTTA
TCCCTATTCGTACGCTGCAGGTCGAC) and 10KbUP.II and cloned approximately 
10 kb upstream from the 31-bp insert in trp5. The diploid strains SAS-150 and -151, -162 
and -163, -166 and -167, -215 and -217, -207 and -209, and -211 and -213 were generated 
by mating FRO-872 with FRO-879, SAS-138 and FRO-879, SAS-140 with FRO-879, 
SAS-199 or -200 with FRO-879, SAS-195 or -196 with FRO-879, and SAS-197 or -198 




ura3Δ0), where TRP5 has been replaced by LEU2 [52]. Strains FRO-876 [52], SAS-134 
and -135, and -136 and -137 contain a CORE-wtI-SceI, CORE-K223I, or CORE-D145A 
cassette (with the hygromycin resistance gene and I-SceI site on the “Watson” strand), 
respectively, which was amplified as a PCR product with primers 10KbDW.IS (5’-
CCGAGGTATTGTTGTATATACCACTACTCTGTGATTTTTTTTCACTCTTGTAGG
GATAACAGGGTAATTTCGTACGCTGCAGGTCGAC) and 10KbDW.II (5’-TTTGT 
CATTAGACACTTACCAGTTGATGTTTTCACTTTTTCTTTCCTTCCTTGGATGGA
CGCAAAGAAGT) and cloned approximately 10 kb downstream from the 31-bp insert 
in trp5. Strains SAS-269 and -270, SAS-201 and -202, and -245 and -246 contain a 
CORE-wtI-SceI, CORE-K223I, or CORE-D145A cassette (with the hygromycin 
resistance gene and I-SceI site on the “Crick” strand), respectively, which was amplified 
as a PCR product with primers 10KbDW.opp.IS (5’ –CCGAGGTATTGTTGTATATAC 
CACTACTCTGTGATTTTTTTTCACTCTTGATTACCCTGTTATCCCTATTCGTAC
GCTGCAGGTCGAC) and 10KbDW.II and cloned approximately 10 kb downstream 
from the 31-bp insert in trp5. The diploid strains SAS-152 and -153, -154 and -156, -158 
and -160, -272 and -274, -219 and -221, and -251 and -253 were generated by mating 
FRO-876 with FRO-879, SAS-134 or -135 and FRO-879, SAS-136 or -137 with FRO-
879, SAS-269 or -270 with FRO-879, SAS-201 or -202 with FRO-879, and SAS-245 or -
246 with FRO-879, respectively. 
 
B.3 Human plasmid construction 
Plasmids pET15b ISceI and pET15b ISceI-K223I (kindly provided by F. Gimble, Purdue 




plasmids were digested with NsiI and BamHI to produce a ~740-bp fragment containing 
the gene which was cloned into pFLAG-CMV-6c (Sigma Aldrich, St. Louis, MO) 
between the BamHI and PstI sites. This yielded plasmids pSD1 (wtI-SceI) and pSS1 
(K223I). Plasmid pSD1 was then used as a template for site-directed mutagenesis using 
primers I-SceI D145A.F and I-SceI D145A.R to generate plasmid pSBO1, which 
contains the D145A mutation yielding the D145A gene. Plasmid p67 (a kind gift from M. 
Porteus, Stanford University) contains the wtI-SceI endonuclease gene regulated by a 
CMV/CBA hybrid promoter [60] and was used as a template to construct plasmids p67-
K223I and p67-D145A. First, fragments of the K223I and D145A genes from the internal 
HindIII site to the stop codon were amplified with primers p67clone HindIII.F (5’–
TGTAGTACAGTCATACGCGCATACAAGCTTTCAACAAACTGGCTAACCTG) 
and p67 Clone SceI SalI.R (5’–ATCGTAGTCGTATGTCGACGAATTCTTATTATTT 
CAGGAAAGTTTCGGAG) and blunt-end cloned into the pCR-Blunt II-TOPO vector 
(Invitrogen, Carlsbad, CA). Next, these plasmids were digested with HindIII and SalI to 
produce 400-bp fragments. Plasmid p67 was also digested with these two enzymes, and 
the 400-bp fragments were cloned into the vector. All plasmids were rescued in E. coli 
and confirmed by sequence analysis.  
 
Plasmid pGRdis contains two nonfunctional reporter genes, eGFP and DsRed2, both 
under the CMV promoter oriented opposite from each other and separated by a 300-bp 
spacer. It was constructed as follows: A fragment, containing the entire coding sequence 
of eGFP and amplified as a ~720-bp amplicon through PCR using primers GFP clone 




pSILENCE.R (5 –AAAAAAAGCTTTTACTTGTACAGCTCGTCCA), was digested 
with BamHI and HindIII and cloned into plasmid pSilencer (Invitrogen) between the 
BamHI and HindIII sites to produce plasmid pEGFP17. Primers EGFP disXho.F (5’–
ACGACGGCAACTACAAGACCTGATAAGGCTCGAGCGCGCCGAGGTGAAGTT
CGA) and EGFP disXho.R (5’–TCGAACTTCACCTCGGCGCGCTCGAGCCTTATCA 
GGTCTTGTAGTTGCCGTCGT)  were used to disrupt eGFP between residues 109 and 
110 to insert two stop codons, an XhoI site, and 2 frameshift bases through in vitro 
mutagenesis, producing plasmid pdisEGFP. Next, using primers 300 bp BamHI buff.F 
(5’–TTTCTTCTCAGGATCCGGGTCCATACATTTGCCTTT) and 300 Bam buff.R 
(5’–AAGCTCGATCGGATCCATCAATAATCCCCTTGGTTC) a 300-bp amplicon 
with BamHI tails generated through PCR of part of the URA3 gene from Kluveromyces 
lactis was inserted into plasmid pdisEGFP3 at the BglII site through compatible cloning, 
generating plasmid pdisEGFP300. Separately, plasmid pDsRed2-N1 (Clontech, Mountain 
View, CA) was modified to generate the disrupted DsRed2 marker. Part of the MCS was 
removed through compatible cloning following double digestion with BamHI and BglII. 
Next, the plasmid was linearized at SbfI, and using primers ISceIstop_SbfI.F (5’-
ACAGTGCTAAGTCCTGCAGGACTAATAGTCTAGAATTACCCTGTTATCCCTAA
GCTTCCTGCAGGTAGGAACTCAAT) and ISceIstop_SbfI.R (5’-ATTGAGTTCCTA 
CCTGCAGGAAGCTTAGGGATAACAGGGTAATTCTAGACTATTAGTCCTGCAG
GACTTAGCACTGT) a fragment containing multiple stop codons and the 18-bp I-SceI 
site was cloned in. Next, site-directed mutagenesis was used to remove one of the 
flanking SbfI sites with primers DeltaSbfI.F (5’ –AGAATTACCCTGTTATCCCTAAG 




AGATGAAGCAGCCGTAAGCTTAGGGATAACAGGGTAATTCT). The construct 
was amplified through PCR with primers DsRed2-EGFPclone.F (5’–ACAGTGCTAAG 
TGGATCCACCGTATTACCGCCATGCAT) and DsRed2-EGFPclone.R (5’–ATTGAG 
TTCCTAGAATTCATCTCGGTCTATTCTTTTGA) and blunt-end cloned into the pCR-
Blunt II-TOPO vector. A ~1.8 kb fragment containing the CMV promoter and disrupted 
DsRed2 gene was excised by digestion with EcoRI and cloned into plasmid 
pdisEGFP300, linearized by EcoRI, to produce plasmid pdisEGFP300-disDsRed2. 
Finally, a ~150-bp fragment, containing the HO endonuclease recognition site and 
amplified through PCR using primers HO site XhoI.F (5’-ATCAAGCTAGCTCGAGG 
GTACGGGGATCTAAATAAATTCGTTTTCA) and HO site SalI.R (5’–CGATATCG 
AAGTCGACTACAACCACTCTACAAAACCAAAACCAGGG), was digested with 
XhoI and SalI. Plasmid pdisEGFP300-disDsRed2 was linearized by XhoI, and the 
fragment was cloned into this site, leaving a unique XhoI site on the plasmid. All 









Table B.1 Oligos used for repair assays 
 
Gene Oligo Size Sequence 
TRP5 TRP5.80F 80-mer 5’ –GTCTAAGAGAGTTGGAAAAGGGTTTTGATGAAGCTGTC 
GCGGATCCCACATTCTGGGAAGACTTCAAATCCTTGTATTCT 
TRP5 TRP5.80R 80-mer 
5’ – AGAATACAAGGATTTGAAGTCTTCCCAGAATGTGGGAT 
CCGCGACAGCTTCATCAAAACCCTTTTCCAACTCTCTTAGAC 
GFP GFP80.F 80-mer 5’ –GCGCACCATCTTCTTCAAGGACGACGGCAACTACAAGAC 
GCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACC 
GFP GFP80.R 80-mer 5’ – GGTTCACCAGGGTGTCGCCCTCGAACTTCACCTCGGCGC 
GCGTCTTGTAGTTGCCGTCGTCCTTGAAGAAGATGGTGCGC 
DsRed2 DsRed2.80F 80-mer 
5’ – GGCGGCGTGGCGACCGTGACCCAGGACTCCTCCCTGCAG 
GACGGCTGCTTCATCTACAAGGTGAAGTTCATCGGCGTGAA 
DsRed2 DsRed2.80R 80-mer 
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